Implants for spinal fixation and or fusion

Description

INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. For example, this application incorporates by reference in their entireties U.S. Patent Publication No. 2011/0087294, U.S. Patent Publication No. 2011/0087296, U.S. Patent Publication No. 2011/0118785, and U.S. Patent Publication No. 2011/0125268.

FIELD

The present disclosure generally relates to bone implants. More specifically, the present disclosure relates to bone implants used for the stabilization, fixation and/or fusion of the sacroiliac joint and/or the spine.

BACKGROUND

Many types of hardware are available both for the fixation of bones that are fractured and for the fixation of bones that are to be fused (arthrodesed).

For example, the human hip girdle is made up of three large bones joined by three relatively immobile joints. One of the bones is called the sacrum and it lies at the bottom of the lumbar spine, where it connects with the L5 vertebra. The other two bones are commonly called “hip bones” and are technically referred to as the right ilium and-the left ilium. The sacrum connects with both hip bones at the sacroiliac joint (in shorthand, the SI-Joint).

The SI-Joint functions in the transmission of forces from the spine to the lower extremities, and vice-versa. The SI-Joint has been described as a pain generator for up to 22% of lower back pain.

To relieve pain generated from the SI-Joint, sacroiliac joint fusion is typically indicated as surgical treatment, e.g., for degenerative sacroiliitis, inflammatory sacroiliitis, iatrogenic instability of the sacroiliac joint, osteitis condensans ilii, or traumatic fracture dislocation of the pelvis. Currently, screws and screws with plates are used for sacroiliac fusion. At the same time the cartilage is generally removed from the “synovial joint” portion of the SI-Joint. This requires a large incision to approach the damaged, subluxed, dislocated, fractured, or degenerative joint.

Additionally, long constructs can be used to join, fuse and/or stabilize a plurality of vertebrae in the thoracic, lumbar, and sacral portions of the spine. These long constructs may include one or more rods. For example, to treat spinal disorders such as degenerative scoliosis, the L5 vertebra to the S1 vertebrae can be fused using a system of implants and rods as described herein.

SUMMARY OF THE DISCLOSURE

The disclosure herein generally relates to one or more of bone implants, their methods of use, or their methods of assembly. The implants herein may be used in one or both of the treatment of a SI-Joint, or as an anchoring component for a construct that joins, fuses and/or stabilizes vertebrae.

One aspect of the disclosure is an implant for use in at least one of bone fusion or stabilizing a plurality of bones. The implant includes a distal anchoring region and a growth region that is proximal to the distal anchoring region, the distal anchoring region having one or more distal surface features that adapt the distal anchoring region for anchoring into iliac bone, and the growth region includes one or more growth features that adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth.

The implant is optionally a composite implant. A composite implant may have an inner elongate member such as a shank and an outer elongate member such as a sleeve. An inner shank may have a distal end region with one or more threads sized and configured for anchoring into iliac bone. An outer sleeve can be sized and configured to be positioned over at least a portion of the inner shank. A sleeve may be positioned relative to an inner member to form a composite implant with an inner member interface feature and a sleeve interface feature interfacing each other so as to resist relative motion between the sleeve and the inner member in at least one direction.

A distal anchoring region can have one or more distal surface features that better adapt the distal anchoring region for anchoring into iliac bone than the growth region, and the growth region can have one or more growth features that better adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth than the anchoring region.

An inner member (e.g. an inner shank) may be more resistant to fatigue than an outer member (e.g. an outer sleeve).

The implants herein are optionally not composite implants.

One aspect of the disclosure herein includes a method of implanting an implant, optionally a composite implant, for use in at least one of fusing or stabilizing bony tissue. The method includes advancing the implant along a posterior sacral alar-iliac (“SAI”) trajectory until a distal anchoring region is disposed in iliac bone and growth region is disposed across the SI Joint. The method can include coupling a tulip or other coupling member to the implant, and optionally coupling a construct member (e.g. rod), to the tulip.

One aspect of the disclosure is a method of assembling a composite bone implant for use in one or more of fusing or stabilizing bone. The method includes positioning an outer member (e.g. sleeve) such that the outer member is disposed over an inner member (e.g. inner shank). Forming the composite implant may include forming a composite implant such that an inner member (e.g. shank) interface feature and a sleeve interface feature interface each other so as to resist relative motion between the sleeve and the inner member in at least one direction. A composite implant may have a distal anchoring region and a growth region that is proximal to the distal anchoring region, the distal anchoring region optionally having one or more distal surface features that better adapt the distal anchoring region for anchoring into iliac bone than the growth region, and the growth region optionally having one or more growth features that better adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth than the anchoring region.

One aspect of the disclosure is an inner shank that can be used as part of a composite bone implant. The inner shank can include any of the features described or claimed herein.

One aspect of the disclosure is an outer sleeve that can be used as part of a composite bone implant. The outer sleeve can include any of the features described or claimed herein.

In some merely exemplary embodiments, an implant for use in fusing and or stabilizing a plurality of bones is provided with a shank portion, a body portion and a head portion. The shank portion has a proximal end and a distal end. The body portion is coupled to the shank portion and is configured to be placed through a first bone segment, across a bone joint or fracture and into a second bone segment. The body portion is configured to allow for bony on-growth, ingrowth and through-growth. The head portion is coupled to the proximal end of the shank portion and is configured to couple the shank portion to a stabilizing rod.

A body portions as used in this context may include any of the sleeves herein.

In some embodiments of the above implants, the distal end of the shank portion is provided with threads for securing the implant to the second bone segment. In some embodiments, the first bone segment is a sacrum and the second bone segment is an ilium. The body portion may be integral with the shank portion. The body portion may include at least one rectilinear face to prevent rotation. In some embodiments, the body portion has a cross-section transverse to a longitudinal axis that is triangular in shape to prevent rotation. The body portion may include at least one apex to prevent rotation. In some embodiments, the body portion includes a plurality of fenestrations that each communicate with a central lumen of the body portion. The shank portion may include at least one spline that mates with a slot within the body portion to prevent relative rotation between the shank portion and the body portion.

In some embodiments, an implant for use in fusing and or stabilizing a plurality of bones is provided with a shank portion, a body portion and a head portion. The shank portion has a proximal end and a distal end. The body portion is coupled to the shank portion and is configured to be placed into a first bone segment. The body portion is configured to allow for bony on-growth, ingrowth and through-growth. The head portion is coupled to the proximal end of the shank portion and is configured to couple the shank portion to a stabilizing rod.

In some embodiments, the first bone segment is a vertebra, a sacrum or an ilium. The distal end of the shank portion may be provided with threads for securing the implant to the second bone segment. In some embodiments, the body portion is integral with the shank portion. In some embodiments, the body portion includes at least one rectilinear face to prevent rotation. The body portion may have a cross-section transverse to a longitudinal axis that is triangular in shape to prevent rotation. In some embodiments, the body portion includes at least one apex to prevent rotation. The body portion may include a plurality of fenestrations that each communicate with a central lumen of the body portion. In some embodiments, the shank portion includes at least one spline that mates with a slot within the body portion to prevent relative rotation between the shank portion and the body portion. The distal end of the shank portion may be provided with a plurality of bristles to allow the shank portion to be distally inserted into a bone but inhibit proximal removal from the bone.

One aspect of the disclosure is an implant for use in at least one of fusing or stabilizing bony tissue, comprising: an elongate body sized and configured such that the elongate body can be implanted across a sacro-iliac (“SI”) joint and extend into a sacrum and into an ilium (optionally to or beyond a tear-drop shaped region); a distal anchoring region of the elongate body having one or more distal surface features that are configured to anchor the distal anchoring region to iliac bone, and a proximal region of the elongate body disposed proximal to the distal region, the proximal region having one or more proximal surface features adapted to allow at least one of bony on-growth, in-growth, or through-growth.

One aspect of this disclosure is a bone stabilizing implant, comprising: an elongate implant body; and one or more deployable members, the one or more deployable members each having a non-deployed position and a deployed position relative to the elongate implant body. An elongate implant body can include one or more threads, optionally a plurality of regions having different number of leads. An elongate implant can include a plurality of rows of openings (optionally linear rows), each of the rows including a plurality of openings separated by a portion of the elongate implant body. A portion of the elongate implant body that separates the plurality of openings can include one or more threads. Any of the deployable members can include a plurality of protrusions extending from a spine, the protrusions extending further radially outward than the spine, and optionally the protrusions formed integrally with the spine. One or more deployable members can be positioned relative to the elongate implant body such that they are deployed upon actuation of an internal deployment member. An internal deployment member can comprise a plurality of radially protruding camming surfaces that when rotated cause the one or more deployable members to move radially outward. One or more threads on an elongate implant body can provide a mechanical radial stop to one or more deployable members, optionally preventing the opening(s) from bowing under load. Any of the openings may be tapered to limit play between an elongate implant body and one or more deployable members. An elongate implant body can have one or more lattice sections.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates an embodiment of an implant structure.

FIGS. 2A-2D are side section views of the formation of a broached bore in bone according to one embodiment of the invention.

FIGS. 2E and 2F illustrate the assembly of a soft tissue protector system for placement over a guide wire.

FIGS. 3 and 4 are, respectively, anterior and posterior anatomic views of the human hip girdle comprising the sacrum and the hip bones (the right ilium, and the left ilium), the sacrum being connected with both hip bones at the sacroiliac joint (in shorthand, the SI-Joint).

FIGS. 5 to 7A and 7B are anatomic views showing, respectively, a pre-implanted perspective, implanted perspective, implanted anterior view, and implanted cranio-caudal section view, the implantation of three implant structures for the fixation of the SI-Joint using a lateral approach through the ilium, the SI-Joint, and into the sacrum.

FIGS. 8A to 8C illustrate embodiments of an implant structure with a head portion joined using a Morse taper.

FIG. 9 illustrates an embodiment of an implant structure with a head portion joined using a screw type attachment.

FIGS. 10A and 10B illustrate an embodiment of an implant structure with an integrated head portion.

FIGS. 11A and 11B illustrate embodiments of an implant structure suitable for pedicle screw salvage.

FIG. 12 illustrates an embodiment of an implant structure with an anchor.

FIGS. 13A and 13B illustrate the attachment of a tulip structure to an implant structure and the securing of a rod to the tulip structure.

FIGS. 14 and 15 illustrate alternative embodiments of head portions with expandable attachment features.

FIG. 16 illustrates an embodiment of an implant structure with a screw-like head portion that extends completely through the stem portion of the implant structure.

FIG. 17 illustrates an embodiment of the attachment of the head portion to the stem portion of the implant structure using a ball and socket joint.

FIGS. 18A to 18E illustrate the head portion of the implant structure in connection with a tulip structure.

FIGS. 19A and 19B illustrate a lateral view and an axial view of an embodiment of the implant structure crossing the SI-Joint using a posterolateral approach entering from the posterior iliac spine of the ilium, angling through the SI-Joint, and terminating in the sacral alae.

FIG. 20A is an anatomic posterior perspective view, exploded prior to implantation, of a representative configuration of an assembly of one or more implant structures, sized and configured to achieve translaminar lumbar fusion in a non-invasive manner and without removal of the intervertebral disc.

FIG. 20B is an anatomic inferior transverse plane view showing the assembly shown in FIG. 20A after implantation.

FIG. 21A is an anatomic posterior perspective view, exploded prior to implantation, of a representative configuration of an assembly of one or more implant structures, sized and configured to achieve lumbar facet fusion, in a non-invasive manner.

FIG. 21B is an anatomic inferior transverse plane view showing the assembly shown in FIG. 21A after implantation.

FIG. 21C is an anatomic lateral view showing the assembly shown in FIG. 21A after implantation.

FIG. 22A is an anatomic posterior view showing, in an exploded view prior to implantation, another representative configuration of an assembly of one or more implant structures sized and configured to achieve fusion between lumbar vertebra L5 and sacral vertebra S1, in a non-invasive manner and without removal of the intervertebral disc, using a posterolateral approach entering from the posterior iliac spine of the ilium, angling through the SI-Joint, and terminating in the lumbar vertebra L5.

FIG. 22B is an anatomic posterior view showing the assembly shown in FIG. 22A after implantation.

FIG. 23A is an anatomic anterior perspective view showing, in an exploded view prior to implantation, a representative configuration of an assembly of one or more implant structures, sized and configured to stabilize a spondylolisthesis at the L5/S1 articulation.

FIG. 23B is an anatomic anterior perspective view showing the assembly shown in FIG. 23A after implantation.

FIG. 23C is an anatomic lateral view showing the assembly shown in FIG. 23B.

FIG. 24 is an axial view illustrating an implant inserted through a posteromedial approach.

FIG. 25A is a perspective view showing an exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end.

FIG. 25B is an exploded view showing the components of the bone implant of FIG. 25A.

FIG. 25C is a side view showing the bone implant of FIG. 25A.

FIG. 25D is a top plan view showing the bone implant of FIG. 25A.

FIG. 25E is a distal end view showing the bone implant of FIG. 25A.

FIG. 25F is a side sectional view schematically showing a portion of the bone implant of FIG. 25A.

FIG. 25G is a side sectional view schematically showing a variation of a portion of the bone implant of FIG. 25A.

FIG. 26A is a perspective view showing an exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end.

FIG. 26B is an exploded view showing the components of the bone implant of FIG. 26A.

FIG. 26C is a side view showing the bone implant of FIG. 26A.

FIG. 26D is a top plan view showing the bone implant of FIG. 26A.

FIG. 26E is a distal end view showing the bone implant of FIG. 26A.

FIG. 27A is a perspective view showing an exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end.

FIG. 27B is a side sectional view showing the bone implant of FIG. 27A.

FIG. 28A is a perspective view showing an exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end.

FIG. 28B is a side sectional view showing the bone implant of FIG. 28A.

FIG. 29A is a perspective view showing an exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end.

FIG. 29B is a side sectional view showing the bone implant of FIG. 29A.

FIG. 30A is a perspective view showing an exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end.

FIG. 30B is a side sectional view showing the bone implant of FIG. 30A.

FIG. 31 is an example of a composite implant.

FIGS. 32A and 32B illustrate imaging showing an exemplary SAI trajectory for implanting a SI Joint stabilization implant across the SI joint, with the arrow indicating the trajectory.

FIG. 33A illustrates an exemplary composite implant.

FIG. 33B illustrates an exemplary elongate inner member.

FIG. 33C illustrates an exemplary outer member.

FIGS. 34A and 34B illustrate an exemplary composite implant.

FIG. 35 illustrate an exemplary inner member.

FIGS. 36A-36C illustrate views of an exemplary composite implant.

FIG. 37 illustrates an exemplary inner member.

FIG. 38 illustrates an exemplary inner member.

FIG. 39 illustrates a portion of an exemplary composite implant.

FIG. 40 illustrates a portion of an exemplary composite implant.

FIGS. 41A and 41B illustrate portions of an exemplary composite implant.

FIG. 42 illustrates a portion of an exemplary composite implant.

FIG. 43 illustrates a portion of an exemplary composite implant.

FIGS. 44A and 44B illustrates views of an exemplary composite implant.

FIG. 44C illustrates an exemplary inner member.

FIGS. 45A and 45B illustrate an exemplary composite implant.

FIGS. 46A-46D illustrates views of an exemplary composite implant.

FIG. 46E illustrates an exemplary inner member.

FIG. 47 illustrates an exemplary composite implant.

FIGS. 48A, 48B, 48C, 48D, 48E, 48F, 48G and 48H illustrate an exemplary implant with one or more deployable members.

DETAILED DESCRIPTION

Elongated, stem-like implant structures 20 like that shown in FIG. 1 make possible the fixation of the SI-Joint (shown in anterior and posterior views, respectively, in FIGS. 3 and 4) in a minimally invasive manner. These implant structures 20 can be effectively implanted through the use a lateral surgical approach. The procedure is desirably aided by conventional lateral, inlet, and outlet visualization techniques, e.g., using X-ray image intensifiers such as a C-arms or fluoroscopes to produce a live image feed, which is displayed on a TV screen.

In one embodiment of a lateral approach (see FIGS. 5, 6, and 7A/B), one or more implant structures 20 are introduced laterally through the ilium, the SI-Joint, and into the sacrum. This path and resulting placement of the implant structures 20 are best shown in FIGS. 6 and 7A/B. In the illustrated embodiment, three implant structures 20 are placed in this manner. Also in the illustrated embodiment, the implant structures 20 are rectilinear in cross section and triangular in this case, but it should be appreciated that implant structures 20 of other rectilinear cross sections can be used.

Before undertaking a lateral implantation procedure, the physician identifies the SI-Joint segments that are to be fixated or fused (arthrodesed) using, e.g., the Fortin finger test, thigh thrust, FABER, Gaenslen's, compression, distraction, and diagnostic SI-Joint injection.

Aided by lateral, inlet, and outlet C-arm views, and with the patient lying in a prone position, the physician aligns the greater sciatic notches and then the alae (using lateral visualization) to provide a true lateral position. A 3 cm incision is made starting aligned with the posterior cortex of the sacral canal, followed by blunt tissue separation to the ilium. From the lateral view, the guide pin 38 (with sleeve (not shown)) (e.g., a Steinmann Pin) is started resting on the ilium at a position inferior to the sacrum end plate and just anterior to the sacral canal. In the outlet view, the guide pin 38 should be parallel to the sacrum end plate and in the inlet view the guide pin 38 should be at a shallow angle anterior (e.g., 15 degrees to 20 degrees off the floor, as FIG. 7B shows). In a lateral view, the guide pin 38 should be posterior to the sacrum anterior wall. In the outlet view, the guide pin 38 should be superior to the first sacral foramen and lateral of mid-line. This corresponds generally to the sequence shown diagrammatically in FIGS. 2A and 2B. A soft tissue protector (not shown) is desirably slipped over the guide pin 38 and firmly against the ilium before removing the guide pin sleeve (not shown).

Over the guide pin 38 (and through the soft tissue protector), the pilot bore 42 is drilled in the manner previously described, as is diagrammatically shown in FIG. 2C. The pilot bore 42 extends through the ilium, through the SI-Joint, and into the S1. The drill bit 40 is removed.

The shaped broach 44 is tapped into the pilot bore 42 over the guide pin 38 (and through the soft tissue protector) to create a broached bore 48 with the desired profile for the implant structure 20, which, in the illustrated embodiment, is triangular. This generally corresponds to the sequence shown diagrammatically in FIG. 2D. The triangular profile of the broached bore 48 is also shown in FIG. 5.

FIGS. 2E and 2F illustrate an embodiment of the assembly of a soft tissue protector or dilator or delivery sleeve 200 with a drill sleeve 202, a guide pin sleeve 204 and a handle 206. In some embodiments, the drill sleeve 202 and guide pin sleeve 204 can be inserted within the soft tissue protector 200 to form a soft tissue protector assembly 210 that can slide over the guide pin 208 until bony contact is achieved. The soft tissue protector 200 can be any one of the soft tissue protectors or dilators or delivery sleeves disclosed herein. In some embodiments, an expandable dilator or delivery sleeve 200 as disclosed herein can be used in place of a conventional soft tissue dilator. In the case of the expandable dilator, in some embodiments, the expandable dilator can be slid over the guide pin and then expanded before the drill sleeve 202 and/or guide pin sleeve 204 are inserted within the expandable dilator. In other embodiments, insertion of the drill sleeve 202 and/or guide pin sleeve 204 within the expandable dilator can be used to expand the expandable dilator.

In some embodiments, a dilator can be used to open a channel though the tissue prior to sliding the soft tissue protector assembly 210 over the guide pin. The dilator(s) can be placed over the guide pin, using for example a plurality of sequentially larger dilators or using an expandable dilator. After the channel has been formed through the tissue, the dilator(s) can be removed and the soft tissue protector assembly can be slid over the guide pin. In some embodiments, the expandable dilator can serve as a soft tissue protector after being expanded. For example, after expansion the drill sleeve and guide pin sleeve can be inserted into the expandable dilator.

As shown in FIGS. 5 and 6, a triangular implant structure 20 can be now tapped through the soft tissue protector over the guide pin 38 through the ilium, across the SI-Joint, and into the sacrum, until the proximal end of the implant structure 20 is flush against the lateral wall of the ilium (see also FIGS. 7A and 7B). The guide pin 38 and soft tissue protector are withdrawn, leaving the implant structure 20 residing in the broached passageway, flush with the lateral wall of the ilium (see FIGS. 7A and 7B). In the illustrated embodiment, two additional implant structures 20 are implanted in this manner, as FIG. 6 best shows. In other embodiments, the proximal ends of the implant structures 20 are left proud of the lateral wall of the ilium, such that they extend 1, 2, 3 or 4 mm outside of the ilium. This ensures that the implants 20 engage the hard cortical portion of the ilium rather than just the softer cancellous portion, through which they might migrate if there was no structural support from hard cortical bone. The hard cortical bone can also bear the loads or forces typically exerted on the bone by the implant 20.

The implant structures 20 are sized according to the local anatomy. For the SI-Joint, representative implant structures 20 can range in size, depending upon the local anatomy, from about 35 mm to about 60 mm in length, and about a 7 mm inscribed diameter (i.e. a triangle having a height of about 10.5 mm and a base of about 12 mm). The morphology of the local structures can be generally understood by medical professionals using textbooks of human skeletal anatomy along with their knowledge of the site and its disease or injury. The physician is also able to ascertain the dimensions of the implant structure 20 based upon prior analysis of the morphology of the targeted bone using, for example, plain film x-ray, fluoroscopic x-ray, or MRI or CT scanning.

Using a lateral approach, one or more implant structures 20 can be individually inserted in a minimally invasive fashion across the SI-Joint, as has been described. Conventional tissue access tools, obturators, cannulas, and/or drills can be used for this purpose. Alternatively, the novel tissue access tools described above and in U.S. Application No. 61/609,043, titled “TISSUE DILATOR AND PROTECTOR” and filed Mar. 9, 2012, which is hereby incorporated by reference in its entirety, can also be used. No joint preparation, removal of cartilage, or scraping are required before formation of the insertion path or insertion of the implant structures 20, so a minimally invasive insertion path sized approximately at or about the maximum outer diameter of the implant structures 20 can be formed.

The implant structures 20 can obviate the need for autologous bone graft material, additional pedicle screws and/or rods, hollow modular anchorage screws, cannulated compression screws, threaded cages within the joint, or fracture fixation screws. Still, in the physician's discretion, bone graft material and other fixation instrumentation can be used in combination with the implant structures 20.

In a representative procedure, one to six, or perhaps up to eight, implant structures 20 can be used, depending on the size of the patient and the size of the implant structures 20. After installation, the patient would be advised to prevent or reduce loading of the SI-Joint while fusion occurs. This could be about a six to twelve week period or more, depending on the health of the patient and his or her adherence to post-op protocol.

The implant structures 20 make possible surgical techniques that are less invasive than traditional open surgery with no extensive soft tissue stripping. The lateral approach to the SI-Joint provides a straightforward surgical approach that complements the minimally invasive surgical techniques. The profile and design of the implant structures 20 minimize or reduce rotation and micromotion. Rigid implant structures 20 made from titanium provide immediate post-op SI-Joint stability. A bony in-growth region 24 comprising a porous plasma spray coating with irregular surface supports stable bone fixation/fusion. The implant structures 20 and surgical approaches make possible the placement of larger fusion surface areas designed to maximize post-surgical weight bearing capacity and provide a biomechanically rigorous implant designed specifically to stabilize the heavily loaded SI-Joint.

To improve the stability and weight bearing capacity of the implant, the implant can be inserted across three or more cortical walls. For example, after insertion the implant can traverse two cortical walls of the ilium and at least one cortical wall of the sacrum. The cortical bone is much denser and stronger than cancellous bone and can better withstand the large stresses found in the SI-Joint. By crossing three or more cortical walls, the implant can spread the load across more load bearing structures, thereby reducing the amount of load borne by each structure. In addition, movement of the implant within the bone after implantation is reduced by providing structural support in three locations around the implant versus two locations.

In some embodiments, the implant structure can function like a pedicle screw to allow fixation and/or fusion of bone such as the spine and/or SI-Joint. For example, long constructs can be used to join, fuse and/or stabilize a plurality of vertebrae in the thoracic, lumbar, and sacral portions of the spine. For example, to treat spinal disorders such as degenerative scoliosis, the L5 vertebra to the S1 vertebrae can be fused using a system of implants and rods as described herein. As illustrated in FIGS. 8A-18E, the implant structure can include a stem portion and a head portion. The stem portion can be formed similarly to the SI-Joint implants described herein and in co-pending U.S. Patent Application Publication 2013/0296953, filed May 6, 2013, titled “Fenestrated Implant” and U.S. Pat. No. 8,202,305 titled “Systems and Method for the Fixation or Fusion of Bone.” A tulip or saddle structure can be attached to the head portion, and a rod can be inserted into and fixed to a plurality of tulip structures attached to implanted implant structures, thereby fusing and/or stabilizing the spine and/or other bones. In some embodiments, the stem portion, head portion, and tulip or saddle structure can all be cannulated and have a lumen that extends longitudinally through the assembled structure such that the assembled structure can be disposed over a guidewire or guide pin.

In some embodiments, as illustrated in FIGS. 8A-8C, the head portion 804 can be separate from the stem portion 802. For example, FIGS. 8A-8C illustrate embodiments of the implant structure 800 with a machine taper such as a Morse Taper. In some embodiments as illustrated in FIG. 8A, the head portion 804 can have a ball portion 806 and a tapered shank 808. The tapered shank 808 can fit into a corresponding tapering cavity 810 in the stem portion 802 to form a taper lock that is held together by friction. The length of the tapered shank 808 can be varied, making the distance between the ball portion 806 and proximal end of the stem portion 802 variable.

In some embodiments as illustrated in FIG. 8B, the head portion 804 can have a tapering cavity 810 while the stem portion 802 can have a tapered shank 808 extending from the proximal end of the stem portion 802. The length of the tapered shank 808 can be varied so that the distance between the head portion 804 and stem portion 802 can be adjusted as desired. In some embodiments, the tapered shank 808 of the stem portion 802 can be angled or curved with respect to the longitudinal axis of the stem portion 802. A curved tapered shank 808 can be useful as described below for the embodiment shown in FIG. 8C.

In some embodiments as illustrated in FIG. 8C, the head portion 804 can have a ball portion 806 and a tapered shank 808 that is curved or angled such that the distal portion of the tapered shank 808 is offset or angled with respect to the ball portion 806 and proximal portion of the tapered shank 808. A curved tapered shank 808 can be useful when a suitable implantation location in one or more bones is not aligned with the other implantation locations. In order for the implant structures 800 to line up with the stabilizing rod, a curved tapered shank 808 can be used so that the head portions 806 all line up with the stabilizing rod even if the implantation locations do not line up.

FIG. 9 illustrates another embodiment of an implant structure 900 with a stem portion 902 and a head portion 904. The head portion 904 can have a ball portion 906 and a shank 908. The shank 908 can have threads 910, like a screw, that can be screwed into a cavity 912 with complementary internal threads. The ball portion 904 can have a screw drive 914 that facilitates turning of the head portion 904. The screw drive 914 can be a slot, socket (square, hex, star, etc.), or other typical screw drive 914 mechanism.

FIGS. 10A and 10B illustrate embodiments of integrated implant structures 1000 having a stem portion 1002 and a head portion 1004 that is integral with the stem portion 1002. As shown in FIGS. 10A and 10B, the head portion 1004 is integral or fixed to the stem portion 1002, and therefore the head portion 1004 has a fixed length relative to the stem portion 1002. As shown in FIG. 10A, the head portion 1004 can have a ball portion 1006 that can be attached to a tulip portion that is described in further detail below in, for example, FIGS. 13A and 18A-18C. Alternatively, as shown in FIG. 10B, the head portion 1004 can have a tulip portion 1007 integrated directly with the stem portion 1002. Having an integrated implant structure 1000 can be useful when it is known in advance that an implant structure 1000 will be used in, for example, a fixation or stabilization procedure that requires the use of an implant structure with a head portion 1004. The integrated implant 1000 can reduce procedure time by not requiring the attachment of the head portion 1004 onto the stem portion 1002. In addition, because the head portion 1004 is integral with the stem portion 1002, the integrated implant 1000 may have a greater structural integrity or strength than an implant assembled from separate pieces.

In some embodiments that may be particularly suited for pedicle screw salvage as illustrated in FIGS. 11A and 11B, the implant structure 1100 can have a stem portion 1102 with ledges or fenestrations 1003 that promote bone ingrowth. Examples of fenestrations that can be incorporated into the implant structure 1100 are described in co-pending U.S. Patent Application Publication 2013/0296953, filed May 6, 2013, titled “Fenestrated Implant.” In some embodiments, the outer surface and/or structure of the stem portion 1102 can be twisted. In some embodiments, the stem portion 1102 may have a round cross-section to better match the cavity within the bone after the old pedicle screw has been removed. In some embodiments, the stem portion 1102 can be tapered. The diameter, shape and profile of the stem portion 1102 can match the bone cavity. In some embodiments, the stem portion 1102 can be oval, round, square, triangular, or rectilinear. In some embodiments, the head portion 1104 can be attached to the stem portion 1102 as described above. For example, the head portion 1104 can be attached to the stem portion 1102 using a Morse taper or screw attachment, or the head portion 1104 can be integral with the stem portion. Pedicle screw salvage can be performed when an implant, such as a pedicle screw, becomes loose within the bone due to windshield wipering or butterflying effects caused by stresses exerted to the bone by the implant. The loose implant can be removed and then replaced by one of the implants described herein.

FIG. 12 illustrates an implant structure 1200 with a stem portion 1202, a head portion 1204 attached to the proximal end of the stem portion 1202, and an anchor 1210 located distally the distal end of the stem portion 1202. The anchor 1210 can be folded into a collapsed configuration during insertion of the implant structure 1200 into bone, and then unfolded and/or expanded into an expanded configuration after insertion. In some embodiments, the anchor 1210 can have one or more arm portions 1212 that are foldable and/or expandable. In some embodiments, the anchor 1210 can be mechanically actuated from the collapsed configuration to the expanded configuration. In some embodiments, the arm portions 1212 can be joined at a hinge or a hub 1214. In some embodiments, the arm portions 12 can be expanded like the frame of an umbrella. In other embodiments, the anchor 1210 can be self-expanding and can be made of a shape memory material such as a nickel titanium alloy. In some embodiments, the anchor 1210 can be restrained by a sheath or other restraining element when in the collapsed configuration. In some embodiments, the anchor 1210 can be attached to and/or extend from the distal end of the stem portion 1202. The anchor 1210 can reduce or prevent implant structure 1200 migration after implantation.

FIGS. 13A and 13B illustrate an implant structure 1300 and a corresponding tulip or saddle structure 1350 that can be attached to the head portion 1304 of the implant structure 1300. The tulip structure 1350 can have a slot 1352 for receiving a rod 1380 that can be used to stabilize the spine. In some embodiments, the tulip structure 1350 can have internal threading 1354 on the two wall portions 1356 that form the slot 1352. In some embodiments, a locking screw 1390 can be used to lock and secure the rod 1380 in place within the tulip structure 1350. The locking screw 1390 can have threading 1392 that correspond to the internal threading 1354 on the two wall portions 1356. To lock and secure the rod in place, the locking screw can simply be screwed in place over the rod 1380. The locking screw 1390 can have a screw drive similar to screw drive 914 described above with respect to FIG. 9. In other embodiments, other fastening mechanisms can be used in place of the locking screw 1390 to hold the rod in place. In some embodiments, the top portions of the wall portions 1356 can be snapped off along a break line 1358. In some embodiments, the break line 1358 can be formed by scoring or thinning the wall portions 1356 along the break line 1358. In some embodiments, the tulip structure 1350 does not have any break lines 1358 or excess wall portions 1356 that can be broken off and can instead have wall portions 1356 that are sized to receive the rod 1380 and locking screw 1390 without having excess material extending past the locking screw 1390.

FIG. 14 illustrates another embodiment of an implant structure 1400 having a stem portion 1402 with a cavity 1412 for receiving an expandable attachment 1410 on the shank 1408 of the head portion 1404. The expandable attachment 1410 on the shank 1408 can have a collapsed configuration and an expanded configuration. The entrance to the cavity 1412 can be a narrowed opening 1414 with a diameter less than the diameter of the cavity 1412. The shank 1408 can be inserted through the narrowed opening 1414 and into the cavity 1412 with the expandable attachment 1410 in the collapsed configuration. Once in the cavity 1412, the expandable attachment 1410 can expand into the expanded configuration, thereby securing the head portion 1404 to the stem portion 1402. The head portion 1404 can have a ball portion 1406 for connected to a tulip structure.

FIG. 15 illustrates another embodiment of a head portion 1504 that can be secured into a cavity 1412 in a stem portion 1402 similar to that illustrated in FIG. 14. The head portion 1504 can have a ball portion 1506 and a shank 1508 with narrowed or undercut portion 1508 and a tapered distal portion 1510. The tapered distal portion 1510 has an end that is narrow enough to be inserted into the narrowed opening 1414. As the tapered distal portion 1510 is further inserted through the narrowed opening 1414, the tapered distal portion 1510 forces the narrowed opening to open wider until the narrowed opening snaps into the undercut portion 1508 of the shank 1508, which in combination with the tapered distal portion 1510 in the cavity, functions to secure the head portion 1504 to the stem portion 1402.

FIG. 16 illustrates another embodiment of a head portion 1604 than can be screwed into an implant structure 1600 in a similar manner as described in connection with FIG. 9, except that in this embodiment, the shank 1608 can have a length that allows the shank 1608 to extend completely through the implant structure 1600. Similarly to the embodiment described in FIG. 9, the shank 1608 can be threaded 1610 and a screw drive on the head portion 1604 can be used to turn the screw like shank 1608. In some embodiments, the threads 1610 on the proximal portion of the shank 1608 can be machine threads for engaging the corresponding threads in the implant structure 1600. The threads 1610 on the distal portion of the shank 1608 can be deeper than the machine threads, which allow the threads to better engage cancellous bone. In some embodiments, the pitch of the threads 1610 can be constant along the length of the shank 1608. In other embodiments, the pitch of the threads 1610 can vary between the different thread types.

FIG. 17 illustrates another embodiment of the attachment of the stem portion 1702 of an implant structure 1700 to a head portion 1704. In this embodiment, the stem portion 1702 has a socket 1708 for receiving a corresponding ball 1706 on the distal end of the head portion 1704. The ball 1706 can reside in the socket 1708 to form a ball and socket joint that permits the head portion 1704 to be rotated through a predetermined angle of rotation. In some embodiments, the angle of rotation can be about 60 degrees or less. In other embodiments, the angle of rotation can be between about 30 to 90 degrees or less.

FIGS. 18A-18E illustrate embodiments of a snap-on tulip or saddle structure 1850. In some embodiments, the tulip structure 1850 can have a slot 1852 for receiving a rod that can be used to stabilize the spine or other bones. In some embodiments, the tulip structure 1850 can have internal threading on the two wall portions 1856 that form the slot 1852. In some embodiments, the wall portions 1856 can have extended tabs that can be snapped off and removed. In some embodiments, the tulip structure 1850 can have a head portion receiving slot 1858 shaped to receive the head portion 1804 attached to the implant structure 1800. The head portion receiving slot 1858 can be located on the distal end of the tulip structure 1850 and provides access to the internal cavity of the tulip structure 1850. The distal end of the tulip structure can have an opening 1860 that allows a portion of the implant structure 1800 to extend through. The diameter or size of the opening 1860 is less than the diameter or size of the head portion 1804, which allows the tulip structure 1850 to receive and then retain the head portion within the cavity of the tulip structure 1850. A stabilizing rod can then be fixed in place within the slot 1852 of the tulip structure 1850, thereby securing the head portion 1804 to the tulip structure 1850.

In some embodiments, the head portion receiving slot 1858 runs up both a portion of one of the side walls and the along the bottom portion to the opening 1860. In some embodiments, the upper portion of the head portion receiving slot 1858 can be circular in shape to accommodate the ball portion of the head portion 1804. The circular portion of the head portion receiving slot 1858 can be located a sufficient distance from the bottom portion of the tulip structure 1850 such that after the ball portion of the head portion 1804 passes into the cavity of the tulip structure 1850, the ball portion drops down against the bottom portion which prevents the ball portion from inadvertently sliding out of the tulip structure 1850. In order for the ball portion of the head portion 1804 to be removed from the tulip structure 1850, the ball portion must be raised from the bottom of the tulip structure 1850 until the ball portion is aligned with the circular portion of the head portion receiving slot 1858, and then the head portion 1804 can be removed from the tulip structure. In some embodiments, the portion of the head portion receiving slot 1858 on the bottom part of the tulip structure can be a straight slot. In other embodiments, the portion of the head portion receiving slot 1858 on the bottom part of the tulip structure can be a curved slot.

The shape and structure of the tulip structure 1850 cavity and opening 1860 allows the tulip structure 1850 to have about a 60 degree angle of movement and rotation after being attached to the head portion 1804. Such a tulip structure 1850 and head portion 1804 can be referred to as poly-axial, meaning the tulip structure 1850 can freely move within a conical area. In other embodiments, the angle of movement and rotation can be between about 30 to 90 degrees or less. Having a substantial angle of movement and rotation allows the implant structure 1800 to be inserted in a wider variety of angles while still allowing the tulip structure 1850 to be aligned with the rod for fixation.

Any of the implants described herein can be used in a variety of surgical procedures, such as stabilization, fixation or fusion of the sacroiliac joint and/or the spine, including vertebra and facet joints. In addition, surgical procedures using a posterior or a posterolateral approach will be particularly suitable for use with the implant structures described herein since the tulip structure of the implant will be aligned with the other implants along the spine after implantation. As described herein, these implant structures can be connected together using a rod that can be secured to each tulip structure. For simplicity, the following procedures will be illustrated and described using a general implant structure 20, but it is understood that any of the implant structures described herein can be used in place of the general implant structure 20.

For example, FIGS. 19A and 19B illustrate a lateral view and an axial view of an embodiment of the implant structure crossing the SI-Joint using a posterolateral approach entering from the posterior iliac spine of the ilium, angling through the SI-Joint, and terminating in the sacral alae.

The posterolateral approach involves less soft tissue disruption that the lateral approach, because there is less soft tissue overlying the entry point of the posterior iliac spine of the ilium. Introduction of the implant structure 20 from this region therefore makes possible a smaller, more mobile incision. Further, the implant structure 20 passes through more bone along the posterolateral route than in a strictly lateral route, thereby involving more surface area of the SI-Joint and resulting in more fusion and better fixation of the SI-Joint. Employing the posterolateral approach also makes it possible to bypass all nerve roots, including the L5 nerve root.

The set-up for a posterolateral approach is generally the same as for a lateral approach. It desirably involves the identification of the SI-Joint segments that are to be fixated or fused (arthrodesed) using, e.g., the Faber Test, or CT-guided injection, or X-ray/MRI of SI-Joint. It is desirable performed with the patient lying in a prone position (on their stomach) and is aided by lateral and anterior-posterior (A-P) c-arms. The same surgical tools are used to form the pilot bore 42 over a guide pin 38, except the path of the pilot bore 42 now starts from the posterior iliac spine of the ilium, angles through the SI-Joint, and terminates in the sacral alae. The pilot bore 42 is shaped into the desired profile using a broach, as before described, and the implant structure 20 is inserted into the broached bore 48. The implant structure 20 is tapped through the soft tissue protector over the guide pin 38 from the posterior iliac spine of the ilium, angling through the SI-Joint, and terminating in the sacral alae, until the proximal end of the implant structure 20 is flush against the posterior iliac spine of the ilium. Because of the anatomic morphology of the bone along the posterolateral route, it may be advisable to introduce implant structures of difference sizes, with the most superior being the longest in length, and the others being smaller in length.

FIG. 20A shows, in an exploded view prior to implantation, a representative configuration of an assembly of one or more implant structures 20 sized and configured to achieve translaminar lumbar fusion in a non-invasive manner and without removal of the intervertebral disc. FIG. 20B shows the assembly after implantation, respectively, in an inferior transverse plane view.

As can be seen in the representative embodiment illustrated in FIGS. 20A and 20B, the assembly comprises two implant structures 20. The first implant structure 20 extends from the left superior articular process of vertebra L5, through the adjoining facet capsule into the left inferior articular process of vertebra L4, and, from there, further through the lamina of vertebra L4 into an interior right posterolateral region of vertebra L4 adjacent the spinous process. The second implant structure 20 extends from the right superior articular process of vertebra L5, through the adjoining facet capsule into the right inferior articular process of vertebra L4, and, from there, further through the lamina of vertebra L4 into an interior left posterolateral region of vertebra L4 adjacent the spinous process. The first and second implant structures 20 cross each other within the medial lamina of vertebra L4.

The first and second implant structures 20 are sized and configured according to the local anatomy. The selection of a translaminar lumbar fusion (posterior approach) is indicated when the facet joints are aligned with the sagittal plane. Removal of the intervertebral disc is not required, unless the condition of the disc warrants its removal.

A posterior procedure for implanting the assembly of implant structures 20 shown in FIGS. 20A and 20B comprises (i) identifying the vertebrae of the lumbar spine region that are to be fused; (ii) opening an incision, which comprises, e.g., with the patient lying in a prone position (on their stomach), making a 3 mm posterior incision; and (iii) using a guide pin to establish a desired implantation path through bone for the first (e.g., left side) implant structure 20, which, in FIGS. 20A and 20B, traverses through the left superior articular process of vertebra L5, through the adjoining facet capsule into the left inferior articular process of vertebra L4, and then through the lamina of vertebra L4 into an interior right posterolateral region of vertebra L4 adjacent the spinous process. The method further includes (iv) guided by the guide pin, increasing the cross section of the path; (v) guided by the guide pin, shaping the cross section of the path to correspond with the cross section of the implant structure; (vi) inserting the implant structure 20 through the path over the guide pin; (vii) withdrawing the guide pin; and (viii) using a guide pin to established a desired implantation path through bone for the second (e.g., right side) implant structure 20, which, in FIGS. 20A and 20B, traverses through the right superior articular process of vertebra L5, through the adjoining facet capsule into the right inferior articular process of vertebra L4, and through the lamina of vertebra L4 into an interior left posterolateral region of vertebra L4 adjacent the spinous process. The physician repeats the remainder of the above-described procedure sequentially for the right implant structure 20 as for the left, and, after withdrawing the guide pin, closes the incision.

The intimate contact created between the bony in-growth or through-growth region 24 along the surface of the implant structure 20 across the facet joint accelerates bony in-growth or through-growth onto, into, or through the implant structure 20, to accelerate fusion of the facets joints between L4 and L5. Of course, translaminar lumbar fusion between L5 and S1 can be achieved using first and second implant structures in the same manner.

FIG. 21A shows, in an exploded view prior to implantation, a representative configuration of an assembly of one or more implant structures 20 sized and configured to lumbar facet fusion, in a non-invasive manner and without removal of the intervertebral disc. FIGS. 21B and 21C show the assembly after implantation, respectively, in an inferior transverse plane view and a lateral view.

As can be seen in the representative embodiment illustrated in FIGS. 21A to 21C, the assembly comprises two implant structures 20. The first implant structure 20 extends from the left inferior articular process of vertebra L4, through the adjoining facet capsule into the left superior articular process of vertebra L5 and into the pedicle of vertebra L5. The second implant structure 20 extends from the right inferior articular process of vertebra L5, through the adjoining facet capsule into the right superior articular process of vertebra L5 and into the pedicle of vertebra L5. In this arrangement, the first and second implant structures 20 extend in parallel directions on the left and right pedicles of vertebra L5. The first and second implant structures 20 are sized and configured according to the local anatomy. The selection of lumbar facet fusion (posterior approach) is indicated when the facet joints are coronally angled. Removal of the intervertebral disc is not necessary, unless the condition of the disc warrants its removal.

A posterior procedure for implanting the assembly of implant structures 20 shown in FIGS. 21A to 21C comprises (i) identifying the vertebrae of the lumbar spine region that are to be fused; (ii) opening an incision, which comprises, e.g., with the patient lying in a prone position (on their stomach), making a 3 mm posterior incision; and (iii) using a guide pin to established a desired implantation path through bone for the first (e.g., left side) implant structure 20, which, in FIGS. 21A to 21C, traverses through the left inferior articular process of vertebra L4, through the adjoining facet capsule into the left superior articular process of vertebra L5 and into the pedicle of vertebra L5. The method further includes (iv) guided by the guide pin, increasing the cross section of the path; (v) guided by the guide pin, shaping the cross section of the path to correspond with the cross section of the implant structure 20; (vi) inserting the implant structure 20 through the path over the guide pin; (vii) withdrawing the guide pin; and (viii) using a guide pin to establish a desired implantation path through bone for the second (e.g., right side) implant structure 20, which, in FIGS. 21A to 21C, traverses through the right inferior articular process of vertebra L4, through the adjoining facet capsule into the right superior articular process of vertebra L5 and into the pedicle of vertebra L5. The physician repeats the remainder of the above-described procedure sequentially for the right implant structure 20 as for the left and, withdrawing the guide pin, closes the incision.

Of course, transfacet lumbar fusion between L5 and 51 can be achieved using first and second implant structures in the same manner.

FIG. 22A shows, in an exploded view prior to implantation, another representative configuration of an assembly of one or more implant structures 20 sized and configured to achieve fusion between lumbar vertebra L5 and sacral vertebra 51, in a non-invasive manner and without removal of the intervertebral disc. FIGS. 22B and 22C show the assembly after implantation.

As FIGS. 22A and 22B show, the one or more implant structures are introduced in a posterolateral approach entering from the posterior iliac spine of the ilium, angling through the SI-Joint into and through the sacral vertebra 51, and terminating in the lumbar vertebra L5. This path and resulting placement of the implant structures 20 are also shown in FIG. 22C. In the illustrated embodiment, two implant structures 20 are placed in this manner, but there can be more or fewer implant structures 20. Also in the illustrated embodiment, the implant structures 20 are triangular in cross section, but it should be appreciated that implant structures 20 of other cross sections as previously described can be used.

The posterolateral approach involves less soft tissue disruption than the lateral approach, because there is less soft tissue overlying the entry point of the posterior iliac spine of the ilium. Introduction of the implant structure 20 from this region therefore makes possible a smaller, more mobile incision.

The set-up for a posterolateral approach is generally the same as for a lateral approach. It desirably involves the identification of the lumbar region that is to be fixated or fused (arthrodesed) using, e.g., the Faber Test, or CT-guided injection, or X-ray/MRI of the L5-S1 level. It is desirable performed with the patient lying in a prone position (on their stomach) and is aided by lateral and anterior-posterior (A-P) c-arms. The same surgical tools are used to form the pilot bore over a guide pin (e.g., on the right side), except the path of the pilot bore now starts from the posterior iliac spine of the ilium, angles through the SI-Joint, and terminates in the lumbar vertebra L5. The broached bore is formed, and the right implant 20 structure is inserted. The guide pin is withdrawn, and the procedure is repeated for the left implant structure 20, or vice versa. The incision site(s) are closed.

The assembly as described makes possible the achievement of trans-iliac lumbar fusion using a posterolateral approach in a non-invasive manner, with minimal incision, and without necessarily removing the intervertebral disc between L5 and 51.

FIG. 23A shows, in an exploded view prior to implantation, a representative configuration of an assembly of one or more implant structures 20 sized and configured to stabilize the spondylolisthesis at the L5/S1 articulation. FIGS. 23B and 23C show the assembly after implantation.

As shown, the implant structure 20 extends from a posterolateral region of the sacral vertebra 51, across the intervertebral disc into an opposite anterolateral region of the lumbar vertebra L5. The implant structure 20 extends in an angled path (e.g., about 20 degrees to about 40 degrees off horizontal) through the sacral vertebra 51 in a superior direction, through the adjoining intervertebral disc, and terminates in the lumbar vertebra L5.

A physician can employ a posterior approach for implanting the implant structure 20 shown in FIGS. 23A, 23B, and 23C, which includes forming a pilot bore over a guide pin inserted in the angled path from the posterior of the sacral vertebra 51 through the intervertebral disc and into an opposite anterolateral region of the lumbar vertebra L5, forming a broached bore, inserting the implant structure 20, and withdrawing the guide pin. The incision site is then closed. As previously described, more than one implant structure 20 can be placed in the same manner to stabilize a spondylolisthesis.

The physician can, if desired, combine stabilization of the spondylolisthesis, as shown in FIG. 23A/B/C, with a reduction, realigning L5 and S-1. The physician can also, if desired, combine stabilization of the spondylolisthesis, as shown in FIG. 23A/B/C (with or without reduction of the spondylolisthesis), with a lumbar facet fusion, as shown in FIGS. 21A to 21C. The physician can also, if desired, combine stabilization of the spondylolisthesis, as shown in FIG. 23A/B/C, with a decompression, e.g., by the posterior removal of the spinous process and laminae bilaterally.

In addition, in some embodiments as shown in FIG. 24, a posteromedial approach can be used to insert the implant 2400. For example, the implant 2400 can be inserted through the posterolateral sacrum, across the alae, through the SI-joint, and into the ilium where the implant may terminate. As illustrated, the implant 2400 can have a stem portion 2402 that is inserted into the bone and a tulip portion 2404 (which may be a separate component coupled to the implant in any of the examples herein) that remains outside the bone. In some particular implementations, a particular posteromedial approach may be used which is known as an S2 alar-iliac (S2AI) approach. The entry point for the S2AI approach is located at the midpoint between the S1 and S2 foramen and 2 mm medial to the lateral sacral crest. The guidewire and or implant should be placed across the sacro-iliac joint above the superior rim of the sciatic notch.

Any of the implants herein, including any of the composite implants herein, may be implanted based on the general illustration in FIG. 24.

In some implementations, just one implant is placed across each SI-joint using an S2AI trajectory, as depicted in FIG. 24. In other implementations, an implant can be added above and or below each S2AI implant using a lateral approach through the ilium, the SI-Joint, and into the sacrum, such as depicted in FIGS. 6A-7B.

It should be noted that, according to aspects of the present disclosure, a tulip, saddle structure, poly-axial joint, fastening mechanism or other coupling device (such as shown in FIGS. 13A and 13B) can be coupled to the proximal end of any number of bone anchors. For example, a coupling device may be attached to the proximal end of any of the implants previously shown in this disclosure, such as those shown in FIGS. 1 and 8A-18E, to allow the implant to couple with a spinal rod or construct, such as rod 1380 shown in FIG. 13B. In a similar manner, a coupling device may be located on the proximal end of the implant shown in FIGS. 1-2 or the implant shown in FIGS. 31-34 of U.S. Pat. No. 8,734,462. In some embodiments, a coupling device may be attached to the proximal end of any of the implants shown in FIGS. 1B-2B, 9A-9B and 10A-10B of U.S. Patent Application Publication 2013/0245763. In some embodiments, a coupling device may be attached to the proximal end of any of the implants shown in FIGS. 47-49 of U.S. Patent Application Publication 2017/0007409. In some embodiments, a coupling device may be attached to the proximal end of the implant shown in FIG. 12 of U.S. Pat. No. 9,662,157. In some embodiments, a coupling device may be attached to the proximal end of any of the implants shown in FIGS. 7A-9B of U.S. Patent Application Publication 2016/0081810. In some embodiments, a coupling device may be attached to the proximal end of any of the implants shown in FIGS. 11-27 of U.S. Patent Application 62/649,466. In some embodiments, the proximal ends of two or more implants may be joined together with a bridging structure that includes a coupling device for attaching to a spinal rod. In some embodiments, an implant can resemble a staple with two or more prongs for inserting into bone, the implant having a coupling device located on its proximal end.

FIGS. 25A-25G show another exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end (which can be a separate component secured to the implant in a separate tulip coupling step). As best seen in FIG. 25B, implant 2500 includes a shank portion 2502, a body portion 2504 (which may be referred to herein as a sleeve) and a head portion 2506. Any of the head portions herein may be referred to generally as a tulip, may be a separate component than the implant, and can be secured to the implant after the implant has been implanted in place. In this embodiment, the distal end of shank portion 2502 includes threads 2508 for threading the shank portion 2502 into a bone segment. Threads 2508 may include one or more self-tapping cutouts 2510, as best seen in FIG. 25E. The proximal end of shank portion 2502 may be provided with a hexagonal recess (not shown) or other suitable feature to mate with a driver to screw the shank portion 2502 into the bone segment. A central lumen 2512 may be provided along the longitudinal axis of shank portion 2502 to allow it to be placed over a guidewire or guide pin when being implanted.

In this embodiment, body portion 2504 is provided with a central lumen 2514 configured to slide over the proximal end of shank portion 2502. Radially outward extending splines 2516 may be provided at one or more locations on shank portion 2502, as best seen in FIG. 25B, to mate with corresponding grooves along the inner surface of central lumen 2514. Splines 2516 and/or other non-rotating features may be provided on shank portion 2502 and body portion 2504 to prevent the two parts from rotating relative to one another. Splines 2516 and or their corresponding grooves may be tapered to create a tight fit when body portion 2504 is tapped into place over shank portion 2502. Splines may be omitted in the middle of shank portion 2502 as shown to reduce stress concentrations and thereby increase fatigue properties of the implant. In other embodiments (not shown), these non-rotation features may be omitted to permit body portion 2504 to rotate relative to shank portion 2502.

In this embodiment, body portion 2504 has a triangular cross-section to prevent it from rotating relative to surrounding bone. When body portion 2504 is placed across a joint or fracture between two bone segments as previously described, body portion 2504 inhibits the two bone segments from rotating or translating relative to one another. In other embodiments (not shown), the body portion may have a square, rectangular, oval or other cross-sectional shape with at least one rectilinear face and/or at least one apex to similarly prevent rotation. When body portion 2504 is prevented from rotating relative to the surrounding bone by virtue of its non-rotationally shaped cross-section, and when splines 2516 prevent shank portion 2502 from rotating relative to body portion 2504, shank portion 2502 is prevented from rotating relative to the surrounding bone. This arrangement prevents shank portion 2502 from undesirably backing out or migrating further into the bone.

Body portion 2504 may be provided with fenestrations 2518 to allow for bony on-growth, in-growth and through-growth. In this exemplary embodiment, a repeating pattern of spars and cross-struts creates a plurality of triangularly shaped fenestrations on each face of body portion 2504. Each of the fenestrations 2518 opens into the central lumen 2514 of body portion 2504. In some embodiments, body portion 2504 is fabricated using an additive manufacturing process such as 3D printing. Further information on designing and manufacturing fenestrated implants is provided in the applicant's U.S. Pat. No. 9,662,157, filed Sep. 18, 2015, and titled “Matrix Implant.” The distal end of body portion 2504 may also be provided with tapered and rounded leading edges 2520 as shown to facilitate inserting body portion 2504 into one or more bone segments. Trailing edges 2522 having a lesser degree of taper may be provided on the proximal end of body portion 2504 as shown to facilitate removal of body portion 2504 from the bone, if desired. Having less taper on trailing edges 2522 permits better engagement between the proximal end and surrounding cortical bone surfaces.

Head portion 2506 may be provided with a coupler 2524 and a main body 2526 as shown in FIGS. 25A-25E, and a nut (not shown). The nut has external threads that mate with internal threads located in the proximal recess of main body 2526 to tighten a spinal rod (not shown) against the bottom of channels 2528 in main body 2526. As shown in FIG. 25B, the proximal end of shank portion 2502 may be provided with a circumferential rib or barb 2530 for securing head portion 2506 to shank portion 2502 in a snap-fit manner. In some embodiments, main body 2526 is configured to pivot in a poly-axial or spherical manner relative to coupler 2524 and shank portion 2502. In some embodiments, main body 2526 is configured to spin about its main axis relative to coupler 2524 and shank portion 2502. In some embodiments, main body 2526 is configured to immovable relative to coupler 2524 and/or shank portion 2502.

Referring to FIGS. 25F and 25G, central lumen 2514 of body portion 2504 and/or shank portion 2502 may be configured to reduce stress concentrations on shank portion 2502 to help ensure it does not fail in use after it has been implanted. In some prior art implants, repetitive heavy load cycles on the proximal end of shank portion 2502 from a spinal rod connected to the head portion can cause the shank portion to break apart. A typical point of failure is where the shank portion 2502 exits the proximal end of the body portion 2504. According to aspects of the present disclosure, stress concentrations may be reduced in this area to permit greater load cycling without implant failure.

In some embodiments, as shown in FIG. 25F, the proximal end of central lumen 2514 of body portion 2504 may be provided with a curved contour 2532 as shown to more evenly distribute forces between shank portion 2502 and body portion 2504, thereby reducing stress concentrations. In FIG. 25F, the proximal end of shank portion 2502 is depicted in an unloaded state with solid lines and in a deflected state with dashed lines. The degree of deflection is exaggerated in FIG. 25F for ease of understanding. Curved contour 2532 may be provided on just one side of central lumen 2514 in the direction of maximum force, on opposite sides of central lumen 2514, or around the entire circumference of central lumen 2514. In some embodiments, curved contour 2532 may mirror the natural bending profile of shank portion 2502. In particular, the contour may be defined by the following beam deflection formulas:

y=(F·x²)/(6·E·I)(x−3·1)
I=(D⁴−d⁴)π/64

- where
- x=distance in horizontal direction in FIG. 25F
- y=distance in vertical direction in FIG. 25F
- F=force applied to proximal end of shank portion 2502
- E=modulus of elasticity of shank portion 2502
- I=moment of inertia of shank portion 2502
- l=length between where shank portion 2502 is fully supported and the point of force application
- D=outside diameter of shank portion 2502
- d=inside diameter of shank portion 2502

In some embodiments, as shown in FIG. 25G, shank portion 2502′ may be provided with a spherical portion 2534 and body portion 2504′ may be provided with a mating spherical socket. Body portion 2504′ may also be provided with a central lumen 2514′ that tapers outwardly towards both its proximal and distal ends, as shown. With this arrangement, shank portion 2502′ may pivot within body portion 2504′ when a force is applied to its proximal end. The tapered portions may be provided on just one side of central lumen 2514′ in the direction of maximum force, on opposite sides of central lumen 2514′, or around the entire circumference of central lumen 2514′. When shank portion 2502′ reaches the end of its pivoting travel, it is supported by a large surface area of body portion 2504′ at both the proximal and distal ends, and may also be supported at spherical portion 2534. These large areas of support greatly reduce the stress concentrations found in prior art implants, and allow the implant to withstand greater forces and/or a larger number of loading cycles without failure. In the embodiments of FIGS. 25F and 25G, the outer surface of shank portion 2502/2502′ and/or the inner surface of body portion 2504/2504′ may be highly polished to further reduce stress concentrations. In some embodiments the surfaces may have a roughness Ra of between 0.01 and 0.04 microns.

Implant 2500/2500′ may be installed in bone, such as across a bone joint or fracture, in a manner similar to that previously described relative to FIGS. 2A-2F and FIG. 24 (i.e. in an S2AI trajectory). In particular, the bone may be prepared by inserting a guide pin into bone segments, spinning a cannulated drill over the guide pin to drill a pilot hole in the bone, and tapping a cannulated broach over the guide pin to create a bore shaped to receive body portion 2504. In some embodiments, any or all of these steps may be omitted. Shank portion 2502 may then be threaded into the pilot hole using a tool attached to the proximal end of shank portion 2502, as previously described. Body portion 2504 may then be tapped into the bone over the proximal end of shank portion 2502. As body portion 2504 engages the splines 2516 located on the proximal end of shank portion 2502, a small rotational adjustment (no more than 15 degrees, for example), may be needed to rotationally align body portion 2504 with the shaped bore. This adjustment may be made manually, or in some circumstances may occur automatically as the tapered and rounded leading edges 2520 of body portion 2504 engage the shaped bore opening in the bone and automatically rotate the implant as needed while body portion 2504 is being tapped into place. Once body portion 2504 is in place, head portion 2506 may be snapped into place on the proximal end of shank portion 2502. Head portion 2506 may include proximally extending tabs as previously described that may be snapped off at this time. When other portions of a spinal construct (not shown) are also in place, a rod may be placed into channels 2528 and secured in place with a nut, as previously described.

In embodiments having a separate head portion that is assembled to a shank portion during implantation as described above, a variety of different head portions can be provided in a kit without having to provide the entire implant for each head type. For example, head portions can be provided that couple to a 5.0, 5.5, 6.0, or 6.35 mm diameter rod. Shank portions and body portions may also be provided in various lengths, widths and or shapes. With this modular approach, a specific head type may be assembled to a specific shank portion and body portion to create a greater number of combinations without having to stock a separate implant for each combination.

In some embodiments, shank portion 2502 can be installed in the bone, and then a broach can be inserted over the proximal end of installed shank portion 2502 to create a shaped bore. After the broach is removed, body portion 2504 may then be installed over shank portion 2502. In some embodiments, the body portion may include an integrated broach such that the body portion can be installed without first preparing a shaped bore in the bone. In some embodiments, body portion 2504 can be installed in the bone first, and then shank portion 2502 can be installed into the bone through body portion 2504, with or without head portion 2506 attached to shank portion 2502 as it is being installed.

According to aspects of the present disclosure, the arrangement of the current embodiment allows for one portion of an implant to be screwed into place, another portion to be tapped into place, and the two portions locked together to take advantage of the anti-rotational aspects of the tapped in portion. In embodiments without splines or other locking features, the various portions can be implanted separately as previously described, or the assembled implant can be installed as a single unit with the body portion rotating in a shaped bore in the bone as the shank portion is screwed into place. In other embodiments having releasable locking features (not shown), the assembled implant can be installed as a single unit with the locking feature released, allowing the shank portion to rotate relative to the body portion. After the implant is installed, the locking feature can be engaged to prevent rotation.

FIGS. 26A-26E show another exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end. Implant 2600 includes a shank portion 2602, a body portion 2604 and a head portion 2606. Shank portion 2602 and body portion 2604 may be separate components as with previously described implant 2500, or they may be integrally formed as a single component. In this embodiment, the distal end of shank portion 2602 includes bristles 2608 for securing the shank portion 2602 into a bone segment. Bristles 2608 may be angled proximally and may be flexible, thereby providing little resistance when being introduced distally into a bore within a bone, but locking against the bone and preventing proximal withdrawal from the bone. In some embodiments, bristles 2608 are arranged at a 45 degree angle relative to the longitudinal axis of the implant 2600. Bristles 2608 may be integrally formed with shank portion 2602, such as with an additive manufacturing process. Alternatively, bristles 2608 may be separate elements of the same or different material from shank portion 2602 and inserted into holes formed in shank portion 2602. In some embodiments, head portion 2606 serves to contact the outer surface of the bone to prevent implant 2600 from migrating further into the bone. In other embodiments (not shown), another element that is larger in size than the implant bore in the bone may be located on or adjacent to the proximal end of body portion 2604 to prevent implant 2600 from migrating further into the bone while allowing head portion 2606 to maintain a full range of motion relative to shank portion 2602. In other embodiments (not shown), bristles 2608 may be replaced with or augmented by rigid barbed elements. Further details relating to the fabrication and use of bristles and barbs with orthopedic implants may be found in U.S. Pat. No. 5,716,358 to Ochoa et al.

The proximal end of body portion 2604 may be provided with a flat surface (not shown) to allow shank portion 2602 and body portion 2604 to be tapped into place together into the bone segment(s). Alternatively, internal threads (not shown) may be provided to allow a slap-hammer or other insertion instrument to be temporarily attached to the proximal end of body portion 2604 to aid in inserting implant 2600. A central lumen 2612 may be provided along the longitudinal axis of shank portion 2602 and body portion 2604 to allow them to be placed over a guidewire or guide pin when being implanted.

In this embodiment, body portion 2604 has a triangular cross-section to prevent it from rotating relative to surrounding bone. When body portion 2604 is placed across a joint or fracture between two bone segments as previously described, body portion 2604 inhibits the two bone segments from rotating relative to one another. In other embodiments (not shown), the body portion may have a square, rectangular, oval or other cross-sectional shape with at least one rectilinear face and/or at least one apex to similarly prevent rotation.

Body portion 2604 may be provided with fenestrations 2618 to allow for bony on-growth, in-growth and through-growth. In this exemplary embodiment, a repeating pattern of alternating triangularly shaped fenestrations may be provided on each face of body portion 2604. Each of the fenestrations 2618 opens into a central lumen of body portion 2604. In some embodiments, body portion 2604 is fabricated using an additive manufacturing process such as 3D printing. Further information on designing and manufacturing fenestrated implants is provided in the applicant's U.S. Pat. No. 9,662,157, filed Sep. 18, 2015, and titled “Matrix Implant.” The distal end of body portion 2604 may also be provided with tapered leading edges 2620 as shown to facilitate inserting body portion 2604 into one or more bone segments. Trailing edges 2622 having a lesser degree of taper may be provided on the proximal end of body portion 2604 as shown to facilitate removal of body portion 2604 from the bone, if desired. Having less taper on trailing edges 2622 permits better engagement between the proximal end and surrounding cortical bone surfaces.

Head portion 2606 may be provided with a coupler 2624 and a main body 2626 as shown in FIGS. 26A-26E, and a nut (not shown). The nut has external threads that mate with internal threads located in the proximal recess of main body 2626 to tighten a spinal rod (not shown) against the bottom of channels 2628 in main body 2626. As shown in FIG. 26B, the proximal end of body portion 2604 may be provided with a circumferential rib or barb 2630 for securing head portion 2606 to body portion 2604 in a snap-fit manner. In some embodiments, main body 2626 is configured to pivot in a poly-axial or spherical manner relative to coupler 2624 and shank portion 2602. In some embodiments, main body 2626 is configured to spin about its main axis relative to coupler 2624 and shank portion 2602. In some embodiments, main body 2626 is configured to immovable relative to coupler 2624 and/or body portion 2604.

Implant 2600 may be installed in bone, such as across a bone joint or fracture, in a manner similar to that previously described relative to FIGS. 2A-2F. In particular, the bone may be prepared by inserting a guide pin into bone segments, spinning a cannulated drill bit over the guide pin to drill a pilot hole in the bone, and tapping a cannulated broach over the guide pin to create a bore shaped to receive body portion 2604. In some embodiments, any or all of these steps may be omitted. Shank portion 2602 and body portion 2604 may then be tapped into the pilot hole and shaped bore, with or without a tool attached to the proximal end of body portion 2604, as previously described. Once shank portion 2602 and body portion 2604 are in place, head portion 2606 may be snapped into place on the proximal end of body portion 2604. In some implementations, shank portion 2602 and body portion 2604 may be tapped into place with head portion 2606 already installed on the proximal end of body portion 2604. Head portion 2606 may include proximally extending tabs as previously described that may be snapped off at this time. When other portions of a spinal construct (not shown) are also in place, a rod may be placed into channels 2628 and secured in place with a nut, as previously described.

FIGS. 27A and 27B show another exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end. Implant 2700 is a form of sacral alar iliac (SAI) screw and includes a threaded shank portion 2702, a body portion 2704 and a head portion 2706. Threaded shank portion 2702 and head portion 2706 of implant 2700 are similar to those of implant 2500 previously described in reference to FIGS. 25A-25G.

Body portion 2704 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted. In this embodiment, body portion 2704 includes a radially inward portion 2708 that is solid and a radially outward portion 2710 that is a porous bony in-growth region, as shown in FIG. 27B. Radially outward portion 2710 may be formed from a porous plasma spray coating with an irregular surface, which supports stable bone fixation/fusion. This implant structure and the surgical approaches disclosed herein make possible the placement of larger fusion surface areas designed to maximize post-surgical weight bearing capacity and provide a biomechanically rigorous implant designed specifically to stabilize the heavily loaded SI-Joint. In other embodiments, the entire shank portion and body portions can be porous.

Implant 2700 can be made of a variety of materials. For example, the implant can be made of a metal or metal alloy, such as titanium or steel, or a nonmetallic material such as ceramic or polymer. In some embodiments, the implant material can have a certain lattice microstructure formed from microparticles. For example, the lattice microstructure can result in a rough or smooth surface texture, depending on the surface finishing techniques used, such as polishing or application of a metal plasma spray. A 3-D printing process may be used to fabricate some or all of implant 2700, which allows the porosity of the implant or printed portions to be controlled. For example, the implant can have a volume porosity between about 30 and 70 percent, with an average pore size between 100 and 1000 microns. The pores can be largely interconnected, largely unconnected, or a mix of interconnected and unconnected pores. In some embodiments, the pores can be located throughout the material of the implant, including the inner and outer implant surfaces. For example, the fusion of the microparticles that form the implant can result in a porous, semi-porous, or nonporous structure, depending on the degree of fusion between the microparticles. In other embodiments, the pores can be located in a porous coating that can be applied onto the implant. For example, a porous coating can be applied using a titanium plasma spray process, or another metal plasma spray process. The coating can be applied to the outer surfaces of the implant, the interior surfaces of the implant, or both the outer and interior surfaces of the implant. For example, the coating could be preferentially applied to the outer surface of a matrixed implant to provide bony ingrowth and on-growth, and not applied to the inner portion of the implant to maximize bony through-growth within the implant. Also, the coating can be applied preferentially from proximal to distal, or vice versa. The thickness of a porous coating can be between about 500 and 1,500 microns. In addition or alternatively to the porous metal coating, a hydroxyapatite coating can also be applied to the implant. In some embodiments, the porosity can be varied along the length of the implant. In some embodiments, the thickness of the coating can be varied along the length of the implant. In some embodiments, the thickness of the coating applied to the outer surface can be different than the thickness of the inner coating. For example, the outer coating may be greater than the inner coating in some embodiments. In other embodiments, the thickness of the inner and outer coatings can be the same.

FIGS. 28A and 28B show another exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end. Implant 2800 is a form of sacral alar iliac (SAI) screw and includes a threaded shank portion 2802, a body portion 2804 and a head portion 2806. Threaded shank portion 2802 and head portion 2806 of implant 2800 are similar to those of implant 2500 previously described in reference to FIGS. 25A-25G.

Body portion 2804 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted, and may be similar to body portion 2704 previously described in reference to FIGS. 27A and 27B. In this embodiment, body portion 2804 includes fenestrations 2808 that communicate between the exterior surface and a central lumen 2810. Fenestrations 2808 may be circular in shape as shown, or may be formed in other shapes. Fenestrations 2808 may be configured to promote bony on-growth, ingrowth and/or through-growth for faster implant and/or bone joint fusion.

FIGS. 29A and 29B show another exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end. Implant 2900 is a form of sacral alar iliac (SAI) screw and includes a threaded shank portion 2902, a body portion 2904 and a head portion 2906. Threaded shank portion 2902 and head portion 2906 of implant 2900 are similar to those of implant 2500 previously described in reference to FIGS. 25A-25G.

Body portion 2904 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted, and may be similar to body portion 2704 previously described in reference to FIGS. 27A and 27B. In this embodiment, body portion 2904 includes fenestrations 2908 that communicate between the exterior surface and a central lumen 2910. Fenestrations 2908 may be oblong and set at an angle, as shown. In this exemplary embodiment, fenestrations 2908 are all aligned in the same direction as the threads located on the shank portion 2902, but form a more acute angle with the longitudinal axis of implant 2900. Additionally, fenestrations 2908 may be provided with sharp cutting edges, such as along their proximal and/or trailing edges. These cutting edges can scrape bone material from the surrounding bone as implant 2900 is being screwed into place and channel the bone material towards central lumen 2910 to create a self-grafting SAI screw. This bone material may then promote faster bone growth in and/or around implant 2900. Fenestrations 2908 themselves may also promote bony on-growth, ingrowth and/or through-growth for faster implant and/or bone joint fusion.

FIGS. 30A and 30B show another exemplary embodiment of a bone implant having a tulip or coupling device provided at its proximal end. Implant 3000 is a form of sacral alar iliac (SAI) screw and includes a threaded shank portion 3002, a body portion 3004 and a head portion 3006. Threaded shank portion 3002 and head portion 3006 of implant 3000 are similar to those of implant 2500 previously described in reference to FIGS. 25A-25G.

Body portion 3004 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted, and may be similar to body portion 2704 previously described in reference to FIGS. 27A and 27B. In this embodiment, a single set of threads 3008 extends continuously across shank portion 3002 and body portion 3004. On the body portion 3004, the minor diameter or roots of threads 3008 may be filled with or formed by a porous material 3010. The major diameter or crests of threads 3008 may be formed on top of a sleeve of porous material 3010, as shown in FIG. 30B. Alternatively, the major diameter or crests of threads 3008 may be formed integrally with the minor diameter or roots, and the porous material 3010 can simply reside within the roots (not shown.) Porous material 3010 may then promote on-growth to body portion 3004 and in-growth to threads 3008.

FIG. 31 illustrates another exemplary implant for use in at least one of fusing or stabilizing bony tissue, sized and configured such that when the elongate body is implanted via a posterior sacral alar-iliac (“SAI”) trajectory (e.g. S2AI) with a bony entry point between a S1 and a S2 foramen, a distal region of the elongate body extends distal to a sacro-iliac (“SI”) joint and within the outer surfaces of an ilium, and a proximal region of the elongate body is disposed across the SI joint. The implant includes a distal anchoring region having one or more distal surface features adapted to anchor the distal anchoring region relative to iliac bone. The implant also includes a proximal region disposed proximal to the distal region, the proximal region having one or more proximal surface features adapted that facilitate at least one of bony on-growth, in-growth, or through-growth. The implant in FIG. 31 is an example of a composite implant, or an implant that is comprised of two or more components.

The embodiment in FIG. 31 is similar to some regards to the embodiments in FIGS. 25A-30B herein. Any suitable feature described with respect to the embodiments in FIGS. 25A-30B can be included in the embodiments that follow, and visa-versa, unless indicated to the contrary. Implant 3100 includes distal region 3102 configured for anchoring into bone, such as relatively denser cortical bone, and proximal region 3104, which is adapted to facilitate at least one of bony on-growth, in-growth, or through-growth. Distal region 3102 includes at least one thread 3110, and proximal region 3104 includes at least one thread 3112.

As in the embodiments above, proximal region 3104 is adapted to facilitate at least one of bony on-growth, in-growth, or through-growth. In this example, the adaption includes a porous surface 3114, which is formed in between one or more threads. The thread 3112 in the central region of the proximal region is discontinuous, but has an overall helical configuration. The proximal region 3104 includes a plurality of fenestrations 3113 (which are larger than the pores 3114), a subset of which together are disposed in at least a partial helical configuration, as shown in the figure. In this embodiment multiple subsets of the plurality of fenestrations 3113 are each disposed in a partial helical configuration. At least some of the fenestrations are disposed at the location of the thread discontinuities, as shown in the figure.

Implant 3100 includes inner elongate body 3108 and outer elongate body 3106. Inner and outer elongate bodies are adapted to stably interface with one another to resist relative motion in at least one direction. Inner elongate body 3108 includes the thread 3110 on the distal region 3102 of the implant. Outer elongate body 3106 includes the thread 3112 on the proximal region 3104 of the implant. Inner elongate body 3108 has a proximal region 3111 that is non-threaded, which optionally may include a thread that interfaces with an optional internal thread on outer body 3106. Outer body includes a distal region 3107 that includes a dual-lead thread, a central region with a single lead thread, and a proximal dual-thread region 3109. One of the threads from distal region 3107 does not continue into the central region with the single thread. Outer body 3106 also includes relatively large fenestrations 3113, as well as relatively smaller pores 3114 that are in between the threads. Outer elongate body 3106 has a larger outer diameter than inner elongate member 3108. Outer elongate body 3106 can have an inner diameter radially spaced from the outer diameter of the inner elongate body 3108, thereby creating a volume of space radially between the inner and outer elongate bodies 3106 and 3108.

In this exemplary embodiment the inner and outer bodies each have one or more features that allow them to be engaged such that relative movement between the two is resisted in at least one direction, optionally resisting rotation. Outer body 3106 includes one or more surface feature 3121 disposed at a distal end region of the outer body 3106 sized and configured to interface with a protruding feature (optionally linear) on inner elongate body 3108, the interface of which prevents rotation between the outer and inner elongate bodies. In this embodiment rotation is prevented at the distal end of the outer elongate body due to the interfacing features. A wide variety of features can be incorporated onto the inner and outer elongate bodies to provide this functionality, such as that shown and described with reference to FIG. 25B herein.

When implants herein are implanted in a SAI trajectory (e.g. S2AI) for positioning across an SI joint (details of which are described elsewhere herein), a portion of the implant that has one or more surface features specifically adapted to facilitate at least one of bony on-growth, in-growth, or through-growth should be positioned at the location of the SI joint. FIGS. 32A and 32B illustrate imaging showing an SAI trajectory for implanting an SI joint stabilization implant across a SI joint, with the arrow indicating the trajectory. “Joint length” is a distance from the entry point in the sacrum to the subject's SI joint. “Overall length” is a distance from the entry point in the sacrum to the outer boundary of the subject's iliac cortex. Additionally, a distal portion of the implant that will be positioned distal to the SI joint preferably has one or more surface features (e.g., threaded region(s)) that adapt the distal region to effectively anchor in the relatively more dense iliac cortical bone. An important consideration for implantable devices that are implanted across an SI in an SAI trajectory is designing and configuring different regions of the implant based on the tissue that will be adjacent to the region(s) when implanted.

With respect to FIG. 31, for example, implant 3100 includes pores 3114 that span a length so that when implanted in an S2AI trajectory across an SI joint, the pores 3114 will be disposed at the location of the SI joint and will facilitate at least one of bony on-growth, in-growth, or through-growth. It is noted that the pores may also extend into distal region 3102. In this embodiment the single lead thread in the proximal region 3104 allows more space for the pores to be created in the proximal region 3104 of the implant, in this instance in at least some of the regions between the thread(s). Additionally, distal region 3102, which will be implanted distal to the SI joint in the relatively more dense iliac cortical bone, has one or more surfaces features (e.g. thread(s)) that adapt the distal region 3102 to effectively and better anchor into the denser bone. In this example, distal region 3102 includes a dual lead thread (which may be more than dual), causing it to provide better anchoring that the single lead thread in the central region of proximal region 3104. It is noted that the thread in the central region of proximal region 3104 could have a smaller pitch, and still be adapted to facilitate in growth (e.g. with pores). It is thus understood that one or more characteristics (e.g. pitch) of surface features may be the same in both the proximal and distal regions. In this embodiment the pitch is the same, but the distal region has a multiple (dual in this case) lead thread. In the embodiment in FIG. 31, one or more surface features in the proximal and distal regions have different characteristics.

FIGS. 33A-33C illustrate an exemplary embodiment of a composite implant that can be sized and configured for implantation across an SI joint via a SAI trajectory (e.g. S2AI). While implant 3300 is described as being a composite implant composed of a plurality of pieces that are assembled prior to implantation (in this embodiment, two parts), implant 3300 can be modified to be a single, integral unit, that is manufactured from a single component. Implant 3300 includes ingrowth region 3304, which is similar to other implant “proximal regions” herein. Implant 3300 also includes anchoring region 3302, which is similar to other “distal regions” herein. Implant 3300 is similar to implant 3100 in FIG. 31. Any description of implant 3100 may be incorporated into implant 3300, and visa-versa, unless indicated herein to the contrary. Distal anchoring region 3302 includes double lead threads 3301 and 3301′, and distal region 3302 is tapered in the distal direction. Proximal ingrowth region 3304 includes a plurality of larger fenestration 3306, subsets of which have a partial helical formation, as shown. In this embodiment, thread 3303 is continuous (unlike thread 3112) with fenestrations 3306 being disposed between the thread. Proximal region 3304 also includes pores 3305, also disposed between thread 3303. In variations, thread 3303 could have one or more discontinuities (like thread 3112), but could also have sections that make complete turns (at least 360 degrees) in between discontinuities in the thread.

Implant ingrowth region 3304 includes a plurality of fenestrations 3306 and smaller pores 3305, both of which extend through an outer surface and an inner surface of the proximal region, creating a passageway from an inner implant volume (but not the “innermost” volume in this embodiment) to a location outside the implant. Fenestrations 3306 and pores 3305 help adapt the proximal anchoring region to facilitate in-growth.

In this embodiment, implant 3300 includes inner component 3320 (e.g., a screw or screw-like component) and outer component 3340 (e.g., an outer sleeve), which are adapted to be secured relative to one another prior to the implant being fully implanted (e.g. secured prior to any part of the implant being implanted, or secured at some point during the procedure), and which are not integrally formed from the same component. The inner component is an example of an inner shank, and the outer component is an example of a sleeve. Inner component 3320 and outer component 3340 are shown individually, not secured together, in FIG. 33B and FIG. 33C, respectively. In this embodiment, when the inner and outer components are secured together, they interface such that relative motion between the two is restricted in at least one direction (e.g. rotational and/or axial). Inner component can have outer component interface 3321 shown in FIG. 33B, which in this embodiment is a threaded region that can mate with an inner thread on outer component 3340, and when interfaced the distal end of the outer component 3340 is secured to the inner component 3320. The proximal end of outer component can also be secured to the inner component, such as with a threaded connection (e.g. that can include proximal threaded region 3323 on the inner component). In this embodiment inner component includes a non-threaded region 3322, which may be a shaft, such as a smooth shaft. The non-threaded region can be the internal surface of an inner volume disposed between the inner component and the outer component. Non-threaded region 3322 can have any number of surface features meant to facilitate ingrowth, such as a roughened or other similar non-smooth surface. In this embodiment, it is the inner component 3320 that includes the distal anchoring region 3302 of implant 3300, which in this embodiment includes the threads 3301 and 3301′.

FIG. 33C illustrates outer component 3340, which in this embodiment is an outer sleeve that is sized and configured to be advanced over the inner component 3320, the both of which are adapted to be secured relative to one another to resist relative motion therebetween in at least one direction. Outer component 3340 has an internal bore extending therethrough, wherein fenestrations 3306 are created through the inner component 3340, creating communication between the internal bore and the outside of the implant. At the proximal end region of the outer component 3340, there is a second thread 3308, creating a dual thread region at the proximal end region. Thread 3303 extends to the end of the thread region, and in this exemplary embodiment has a constant pitch along its length, but in other embodiment the pitch can vary to some extent. While not shown in FIG. 33C, pores 3305 can be in the outer component between the threads, as in the embodiment in FIG. 31. Optional porous regions 3305 are labeled (only two are labeled) but the pores are not shown in FIG. 33 for clarity. A plurality of individual fenestrations 3306 together extend in a partial helical configuration, even though the fenestrations are considered individual fenestrations. In this embodiment there are three regions of fenestrations that each extend in a partial helical configuration, as shown in the figures. The fenestrations 3306 do not extend into the dual-threaded region at the proximal end of the outer component 3340, nor do they extend all the way to the distal end of the outer component. Any number of the fenestrations 3306 can be tapered (larger outer dimension), as shown. The optional fenestrations can facilitate at least one of bony on-growth, in-growth, or through-growth, as can the optional fenestrations.

The plurality of sets of fenestrations 3306 in this embodiment are configured and oriented so that a physician can see passing through the outer component from one side to the other using radiographic imaging to monitor bony ingrowth and fusion over time.

An exemplary advantage of having a composite implant with two (or more) pieces is that a first (e.g. inner shank) component that is more resistant to fatigue can be manufactured using some common techniques, which may include some common screw manufacturing techniques. The first component (e.g. inner component) may be made from a material that is relatively more resistant to fatigue, such as, for example without limitation, titanium or stainless steel. For example, inner component 3320 shown in FIG. 33B may be made from a relatively more fatigue resistant material, such as titanium, which provides strength to the implant 3300. Additionally, distal anchoring region 3302 can be manufactured using, for example, common screw manufacturing techniques. By selecting a material for the inner component that is stronger and imparts strength to the implant, the second component, such as outer component 3340 (e.g., outer sleeve) shown in FIG. 33C, need not be as fatigue resistant. This provides more options for choosing a design and/or material for the second component, which allows for more design options for the second component, and can thus make easier the process of imparting additional functionality to the implant using design features of the second component. For example, outer component 3340 (e.g., a sleeve) may be designed with certain functionality (e.g., porous and/or roughened surfaces) that causes it to be less fatigue resistant, and optionally much less fatigue resistant, than the inner component. The outer component (e.g., 3340) may be made from a wide variety of materials, such as titanium alloy, polymers, or ceramics. In this embodiment, the outer component, which will be referred to as an outer sleeve, provides several features to the implant. By having an axially extending central bore with an inner diameter greater than the outer diameter of the inner component, the implant has an empty volume between the inner and outer component that helps facilitate the ingrowth of tissue therebetween, which helps stabilize the implant after implantation. The volume of space can also be used to deliver one or more agents into the subject after the implant is positioned in the subject. Additionally, the outer sleeve includes aperture and/or fenestration that can also facilitate the ingrowth of tissue into the volume. The outer sleeve also includes one or more threads, which help anchor the implant at the location of the thread(s), which is this embodiment includes the location of the SI joint.

Any of the composite implants in this disclosure may thus benefit from the exemplary advantages of composite implants set forth herein.

As set forth herein, the implants in FIGS. 25-47 may be implanted across an SI joint and can be advanced using a SAI trajectory (e.g. S2AI), such as is generally shown in FIG. 24 herein. As set forth herein, the different regions of the implant can be configured to provide one or more functions, which may depend on the type of tissue that will be adjacent to the particular region during or after implantation. For example, the SAI implants will preferably have a region, such as proximal region 3304 that when implanted and extends across the SI joint, facilitates at least one of bony on-growth, in-growth, or through-growth. As can be seen from FIGS. 32A and 32B, the proximal region should have a length such that when implanted, will extend across the SI joint. In some embodiments the proximal ingrowth region (e.g., region 3304) has a distal end that extends at least as far as 20 mm from the proximal end of the implant. In this context, the proximal end does not necessarily extend all the way to the proximal end of the implant. The proximal region merely has a distal end that is at least 20 mm away the proximal end of the implant. In some embodiments the distal end is from 20 mm-100 mm from the proximal end of the implant, optionally from 30 mm-75 mm, optionally from 30 mm to 60 mm. In this context, “proximal region” generally refers to a region of the implant that has at least one structural difference than a distal anchoring region that is closer to the implant distal end than the proximal growth region. In the exemplary embodiment in FIGS. 33A-33C, one of the structural differences between the proximal region and the distal region is that proximal region has a threaded region with a lower percentage (of its length) of dual-lead or multi-lead threads. Additional differences in this embodiment include fenestrations and pores present in the proximal anchoring region. The exemplary lengths of the proximal growth regions in this embodiment can be incorporated into other SAI implants herein, such as those in FIGS. 25-30. Any of the lengths of the proximal regions (“proximal region” in these contexts may also refer to “proximal growth regions”) in this context can also be a length of the shank or shaft region 3322 of the inner component.

Other types of implants that may appear to have similar structure and dimensions many not necessary provide the advantages set forth herein. For example, the relative lengths of different sections of the those other implants, in combination with the overall length of those implants, may not necessary be sized to provide the benefits herein when implanted according to methods set herein. For example, other types of implants may not have a distal anchoring section that is sized (including length) and configured for ilium bone anchoring, and a proximal section that is sized (including length) to be positioned across a SI joint when the distal anchoring region is disposed in the ilium, the proximal region adapted to facilitate tissue growth.

The distal anchoring regions (e.g. region 3302 in FIG. 33A) in this context refers generally to a distal region of the implant that does not extend all the way to the proximal end of the implant, and which has one or more structural differences than a more-proximally disposed region, wherein the distal region has one or more structural features that better adapt the distal region for anchoring to tissue than the more proximally disposed region. For example, the distal region 3302 has a higher percentage of dual-lead or multi-lead threads and can be made of stronger material or as a stronger structure than proximal region 3304, adapting it for better anchoring than a more proximally disposed region. The distal region may or may not extend all the way to the distal end of the implant. In the embodiment in FIGS. 33A-C, for example, the distal region is considered to extend all the way to the distal end of the implant. The distal end of the distal anchoring region extends at least as far distally as 40 mm from the proximal end of the implant. Extending at least this far distally adapts the distal region of the implant to better anchor into more dense cortical iliac bone, which will be adjacent the distal region when the implant is implanted in an SAI trajectory. The distal end of the distal region may be from 40 mm to 120 mm away from the proximal end of the implant, optionally from 40 mm to 100 mm, optionally from 40 mm to 80 mm. The distal end of the implant should not breach through the iliac bone and extend out of the iliac bone.

In some embodiments the length of the distal region is from 10 mm to 80 mm, such as from 10 mm to 60 mm, such as from 10 mm to 50 mm, such as from 10 mm to 40 mm, such as from 10 mm to 40 mm, such as 15 mm to 35 mm, such as 20 mm to 30 mm.

The proximal region may be longer than the distal region, such as in the embodiments in FIG. 25-33, but in other embodiments the distal region may have the length as the proximal region. And as set forth above, the “proximal growth region” (e.g. 3304 in FIG. 33A) may not extend as far proximally as in the embodiments in FIG. 25-33 (but the implant may still be adapted to adequately facilitate ingrowth, including at the joint), so the proximal growth region could in some alternative embodiments be the same length or even shorter than the distal anchoring region.

In some embodiments the proximal growth region is longer than the distal anchoring region, and in some embodiments is 1-3 times the length of the distal anchoring region, such as 1.1 times-2.9 times the length of the distal anchoring region. For example, in the embodiment in FIGS. 33A-C, the proximal growth region is from 1-3 times the length of the distal anchoring region, and is from 1-2 times the length of the distal anchoring region. The relative lengths and ratio may depend on wherein the implant regions are disposed after implantation, and the function that is needed from the different implant regions based on the adjacent tissue.

The distal anchoring region (e.g. region 3302, 3102) may be a double lead threaded region, such as the embodiment in FIG. 33A-33C. For example without limitation, the thread pitch may be from 4 mm-8 mm, such as from 5 mm to 7 mm (e.g., 6 mm), with the threaded region having a 3 mm lead. The dual lead threaded region helps adapt the distal anchoring region for enhanced anchoring into the harder cortical bone. The implant 3100 shown in FIG. 31 also has a distal anchoring region with a dual lead threaded region.

In the embodiment in FIGS. 33A-33C, the inner component 3320 includes a shaft region 3322. The shaft outer diameter (“OD”) is less than the inner diameter (“ID”) of the outer sleeve 3340. In some embodiments the distance (i.e., the spacing) between the OD and the ID may be between 0.1 mm and 5 mm, such as from 0.5 mm to 3 mm. As set forth herein, this spacing creates the volume that facilitates growth therein.

In some merely exemplary embodiments, outer component 3340 (e.g. outer sleeve) can have a thread (e.g. 3103) that has a pitch that may be constant along most of its length, as is the case in FIGS. 33A-33. The pitch may be from 3 mm to 9 mm, for example (e.g., from 4 mm-8 mm, such as from 5 mm-7 mm, such as 6 mm), even if the thread has one or more discontinuities along its length (e.g. as in the embodiment in FIG. 31). The threaded region may be single lead along at least 50% of its length or more, as is the case in FIG. 31 and FIGS. 33A-33C, and in these embodiments the threaded region is single lead along at least 75% of its length. The pitch of the threaded region of the outer component can be designed to maintain enough surface area in the body of the outer component to create enough fenestrations (e.g. fenestrations 3114 or 3305), which can facilitate growth.

The outer component in FIG. 31 and in FIGS. 33A-33C includes a proximal region that is dual lead (e.g., 3303 and 3308 in FIG. 33C). Dual-lead and dual-thread are terms that may be used interchangeably in this disclosure. The dual (or double) lead region helps better anchor this region of the implant into the more dense cortex of the sacrum, similar to how the dual lead anchoring region of the implant can be dual lead to provide better anchoring in cortical iliac bone. Any of the implants herein can have this proximal dual lead region.

As set forth herein, the internal surface of the outer component 3340 can have an internal threaded region, which is configured to interface with external threaded region 3321 (see FIG. 33B) on the inner component 3320. This can help secure the internal and outer components.

In some embodiments the outer and inner components are adapted such that when assembled the outer component is put under compression due to the secured engagement between the two components. Components in bending may fail on the surface that is exposed to tension, so pre-stressing one or more components in compression can provide the benefit a higher working load range. Pre-stressing the outer component is, however, optional. Any of the implants herein can be pre-stressed in this manner to provide the benefit of a higher working load range.

With any of the implants herein, the distal end (or proximal end) of the outer component can be secured to the inner component while the proximal end (or distal end) is not secured to resist relative movement in at least one direction. By allowing the proximal end (or distal end) to be freely moveable relative to the inner component, the implant may beneficially be less likely to fatigue, due to fewer forces acting on the implant.

In alternative embodiments, the shaft region of the inner component (e.g. 3322 in FIG. 33B) may include one or more apertures or fenestrations therein, which may be a wide variety of sizes and configurations. Having one or more openings in the inner component could allow a substance (e.g. a therapeutic) to be delivered into an inner channel or bore in the inner component and out the openings, which could also pass through the opening (e.g., apertures, smaller fenestrations) in the outer component and interact with tissue.

It is understood that any suitable feature described with respect to any of the implants in FIG. 25-33 can be incorporated into any other embodiment in FIGS. 25-33, particularly if the feature can be clearly and easily incorporated therein.

Even if not specifically described, the implants disclosed in FIGS. 31-47 include a proximal end region that is configured to be coupled to a tulip, and is similar to the tulip or coupling devices or members at the proximal ends of the implants in FIG. 25-30. Any of the tulip or coupling devices described in the context of FIGS. 25-30 herein are expressly incorporated by reference into the embodiments in FIGS. 31-33. The tulip coupling members are configured to enable the implants to be coupled to other bone stabilization systems, which are described elsewhere herein.

Any of the exemplary features in any of the composite implants herein may be integrated or incorporated into other composite implant examples herein, unless specifically indicated to the contrary.

FIGS. 34A and 34B illustrate side views of an exemplary composite implant (assembled) that can be sized and configured for methods of implantation across a sacro-iliac (SI) joint via a posterior sacral alar-iliac (“SAI”) trajectory, for example a posterior second sacral alar-iliac (“S2AI”) trajectory. FIG. 34A is an assembled side view (without a tulip coupled thereto), while FIG. 34B is a sectional assembled view. Implant 3400 includes a sleeve 3410 and shank 3430, wherein the sleeve is sized and configured to be positioned over at least a portion of the shank. The sleeves herein have an inner lumen sized and configured to receive therethrough an inner member. The has one or more growth surface features adapted to facilitate at least one of bony on-growth, in-growth, or through-growth. The sleeve is positioned relative to the shank to form the composite implant with a shank interface feature and a sleeve interface feature interfacing each other so as to resist relative motion between the sleeve and shank in at least one direction. A shank herein may be referred to as an inner shank in cases where a sleeve is disposed around at least a portion of the shank. Inner and outer in this context refers to relative radial positions, relative to an optional long axis of the implant.

In this embodiment, sleeve 3410 is configured such that it can be front loaded over the shank 3430. That is, the distal end of the shank can be advanced into the proximal end of the sleeve (relative motion) to assemble the shank and sleeve into the assembled configuration shown in FIGS. 34A and 34B.

Sleeve 3410 includes a tapered distal threaded region 3411, any portion of which may be textured. In this embodiment tapered distal threaded region 3411 is a dual lead thread. Sleeve 3410 also includes central region 3412, which includes a single lead as shown, a plurality of fenestrations 3413, and a plurality of discrete lattice sections 3414 (only one labeled). In this example, each of (in other embodiments at least some of) the plurality of fenestrations 3413 is disposed between axially adjacent thread regions, as shown. In this example each of (in other embodiments at least some of) the plurality of lattice sections 3413 is disposed between axially adjacent thread regions, as shown. In this example multiple subsets of the plurality of fenestrations are each disposed to a partial helical configuration, as shown. In this example multiple subsets of the plurality of lattice sections are each disposed to a partial helical configuration, as shown.

Implant 3400 includes a distal anchoring region (“DAR” in FIG. 34B) and growth region (“GR” in FIG. 34B). The distal anchoring region includes one or more distal surface features (in this embodiment threads) that better adapt the distal anchoring region for anchoring into iliac bone than the growth region. The growth region includes one or more growth features that better adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth than the anchoring region (such as more fenestrations 3413, more lattice sections 3414 and single thread versus dual threads).

FIGS. 36A-36C illustrate an exemplary composite implant 3600 that can include any relevant feature of any composite implant (multi-component) herein. Any features not specifically described may be incorporated by reference into this embodiment from other examples herein. Similar features may be similarly labeled in the figures. Implant 3600 includes sleeve 3610 and shank 3630. In the embodiment in FIGS. 36A-C, sleeve 3610 includes a distal tapered threaded region as shown. The distal tapered threaded region includes optional textured surface 3616 on the minor diameter of the threads. As shown in Section B-B from FIG. 36A, as shown in FIG. 36B, lattice sections 3614 are disposed in the sleeve flutes 3615, and the lattice sections 3614. In Section C-C from FIG. 36A, as shown in FIG. 36C, however, the sleeve also includes lattice sections 3614′ that fill the cutting fluid void. In this proximal region of the sleeve, the lattice sections 3614′ essentially fill in, or take the place of, apertures 3613. These through lattice sections 3614′ can increase the amount of tissue growth through sections 3614′. Also shown in FIG. 36C is a volume (or void) defined between the shank outer dimension and the sleeve inner diameter, in which tissue ingrowth can occur.

The sleeve in FIG. 36A-36C is adapted to be front loaded onto the shank. Front loading the sleeve makes it easier to match the locations of the threads on the sleeve and shank.

In any of the composite implant examples herein, the sleeves may be manufactured by printing.

FIG. 35 illustrates an exemplary shank 3530. Any of the shanks herein may also be referred to as an inner member. Shank 3530 includes a distal region 3540, which is threaded in this embodiment and has a dual thread in this embodiment. Distal region 3540 is tapered.

The shank includes a section 3551 and a section 3552, with section 3553 axially in between. Either or both of sections 3551 and 3552 may be textured, such as with TPS, grit blast, HA, for example without limitation, to facilitate one or more of in growth, on-growth, or through growth. Section 3553 can include a central thread as shown. The thread in central section 3553 may be made with the same thread pass as the pass creating the threads on the distal shank section. A benefit of the thread in central section 3553 can be that it creates volume between the sleeve and shank that can increase graft volume while providing support to the sleeve.

Any of the inner members herein, such as any shank herein, can be manufactured by machining the inner member. In some embodiments the inner member can be machined out of a solid material such as titanium. The central rib in section 3553 is an example of a central rib that can be configured to reduce the bending moment on the shank. This can be helpful for relatively longer shank lengths, such as 80-120 mm length shanks.

FIG. 37 illustrates a shank 3700 that includes a central rib 3731. The central rib 3731 is a region with a larger radial dimension than adjacent sections of the shank, as shown in FIG. 37. The rib can increase graft volume, while optionally help stabilize the sleeve.

Any of the shanks herein (one any section thereof) may have one or more holes therethrough, such as to facilitate post-implant administering one or more agents (e.g. PMMA into the ilium).

In any of the examples herein, the sleeve apertures herein may have one angled edge to help cut bone while screwing the implant into position, and the other edge can be straight, as shown in the examples in FIGS. 34A-47. This can help self-harvest the bone and help fill the fenestrations with bone.

FIG. 40 illustrates a portion of composite implant 4000 that includes sleeve 4010 and shank 4030. Optional apertures 4013 are also shown. Any other feature from any other embodiment herein can be incorporated into implant 4000. Implant 4000 includes a shank 4030 that includes optional plurality of holes 4023 that are adapted to function as post-fill graft ports. The holes 4023 can communicate with an inner shank volume to facilitate post-implant filling. In this embodiment apertures 4023 are optionally aligned with holes 4023.

FIGS. 41A and 41B illustrate exemplary composite implant 4100 that includes sleeve 4110 and shank 4130. In this embodiment (or any other embodiment herein), sleeve 4110 includes cutting flutes in the distal region. In this exemplary embodiment, cutting flutes have a 15 degree to 25 degree cutting face 4128, as shown in FIG. 41B. The cutting faces may be angled at other degrees. Implant 4100 includes any other features of any other composite implant herein.

The implant may have one or more ways in which the sleeve interacts with the shank to help stabilize the sleeve relative to the shank when assembled. For example, the shank can have a shank interface feature and the sleeve can have a sleeve interface feature that are configured to interface with each other so as to resist relative motion between the sleeve and the inner shank in at least one direction (e.g. axial, radial, rotational). For example, the sleeve and shank may interface in one or both of a distal anchoring region and a proximal region of the implant to help stabilize the sleeve relative to the shank. In some examples the shank and sleeve do not interface in a central region of the implant.

For example, the shank 4230 may include, in the distal threaded region, a detent, depression, or barb 4239 in a thread, as shown in FIG. 42. The barb 4239 can be configured to interface with the sleeve to prevent sleeve 4210 from advancing too far distally relative to the shank. This may function as a back-up or secondary stop feature if a primary locking mechanism fails.

The sleeve and the shank may alternatively or in addition to interface in a proximal end region of the composite implant to resist relative movement therebetween in at least one direction. FIG. 43 illustrates an exemplary proximal end region locking mechanism, which may be incorporated into any of the composite implants herein. The side sectional view of FIG. 34B also includes the same or similar proximal end region locking mechanism as that shown in FIG. 43. Composite implant 4300 is shown with the sleeve in a model view with lattice regions 4314 and 4314′ illustrated as solid regions. Locking ring 4316 (which can be the same or similar to locking ring 3416 in FIG. 34B) is a separate component, which is configured to snap into grooves in the shank and the sleeve during assembly of the shank and sleeve. The optional annular lock ring functions to prevent potential migration of a loose sleeve.

FIGS. 44A-C are side views of an exemplary composite implant 4400 (FIG. 44C shows shank 4410). FIG. 44B is a side sectional view. FIGS. 44A-44C illustrate additional or alternative ways in which the sleeve and shank can interface to resist relative motion therebetween in at least one direction. The shank and sleeve can have interference-fit threads in thread interface region 4450, as shown in the sectional view of FIG. 44B, which can help resist relative motion between the shank and sleeve. Any portion(s) of the threads may have no clearance therebetween. In these embodiments the sleeve includes internal threads in the distal end region that are configured to interface with the outer threads on the shank.

Alternatively or in addition to, the shank/sleeve interface can include a tapered locking connection in tapered locking connection region 4460. At this interface region the shank and sleeve can include distal tapers as shown, which together form a taper lock.

Alternatively or in addition to, the shank/sleeve interface can include a proximal end region interface in region 4470, which in this embodiment includes a tight sliding fit between optionally smooth surface of the sleeve and shank. The surface 4419 of the shank that sleeve interfaces with is shown in FIG. 44C. FIGS. 44A-44C is an example of a composite implant in which the sleeve and shaft interface in distal end regions and proximal end regions, but does not interface in a central region in between the distal and central regions.

In any of the embodiments herein, the sleeve and shank can interface in a distal region, such as in one or both of regions 4450 and/or 4460 in FIG. 44B, but may not interface in a proximal region (e.g., optionally not in region 4470 in FIG. 44B).

Additionally, if the sleeve and shank interface in a proximal region, the proximal interface region may provide for some relative movement between the sleeve and shank, but can still provide some degree of overall resistance to movement therebetween in at least one direction.

FIGS. 45A and 45B illustrate (in side and sectional side views, respectively) an exemplary composite implant 4500, including sleeve 4510 and shank 4530. Implant 4500 may alternatively or in addition to include any of the features herein of any other composite implant. Shank 4530 illustrates an example of how distal threaded region 4541 and proximal threaded region 4542 may be cut from a blank starting material during the same step so that the threads share the same start. Proximal threaded 4542 can be dual-lead thread as shown, similar to other embodiments shown herein. Region 4519 of outer sleeve is dual-lead, as with other embodiments herein.

FIG. 45B illustrates an exemplary shank/sleeve distal interface that includes a threaded interface between sleeve 4510 and shank 4530. In the interface region 4538 as shown, the shank thread crest optionally becomes gradually flatter in the proximal direction, as shown. That is, the crest is less flat further distally in region 4538 and becomes flatter moving proximally, as shown in FIG. 45B.

Implant 4500 is an example of a composite implant in which the sleeve can be placed under compression upon assembly of the shank, for exemplary benefits set forth herein. For example, components in bending may fail on the surface that is exposed to tension, so pre-stressing one or more components in compression can provide the benefit of a higher working load range. Pre-stressing the outer component is, however, optional. Any of the implants herein can be pre-stressed in this manner to provide the benefit of a higher working load range. Implant 4500 includes shank 4530 that includes stop 4539 in the configuration of a shoulder, as shown. The stop 4339 provides a mechanical stop for sleeve 4510 and help compress the sleeve (pre-strain), for reasons set forth herein. One separate aspect of this disclosure is thus a composite implant wherein an outer member (e.g. sleeve) is put under compression when interfaced with an inner member (e.g. shank). One of the optional benefits of pre-straining/pre-compressing the sleeve would be in cases where the sleeve might or would be more likely to break before the shank due to material properties of the sleeve compared to the shank.

FIG. 46A illustrates an exemplary composite implant 4600, including sleeve 4610 and shank 4630. Implant 4600 may alternatively or in addition to include any other features of other composite implants herein. The other composite implants herein may include any feature of implant 4600. FIGS. 46B-46D illustrate exemplary features of exemplary sleeve 4610. Any of the sleeves herein may be 3D printed, for example. In the sleeve distal thread region shown in FIG. 46B, the thread may have a 5° to 15° back flank angle, for example. FIG. 46C illustrates a central region of exemplary sleeve 4610 in the more centrally disposed growth region of the implant. In this threaded region the thread may have a 0° to 3° back flank angle, for example. FIG. 46D illustrates a proximal region of sleeve 4610, which has a dual lead thread. As shown, the sleeve minor diameter surface 4617 tapers radially outward from the distal end to the proximal end, as shown in both FIGS. 46A and 46D. The major diameter can be maintained constant or substantially constant. The thread may have a 0° to 3° back flank angle, for example. FIG. 46E illustrates a distal end region of exemplary shank 4630. Any of the shanks herein may be machined using a variety of known machining processes. Thread 4637 has a small flat at the crest, as shown, which gradually increases in length in the proximal direction, also as shown. The distal shank thread may optionally include a plurality of cutting flutes in this region, optionally first and second flutes that are 180 degrees from each other. The distal shank thread may optionally have a 10° to 15° back flank angle, for example.

FIG. 47 is a side view that illustrates an exemplary composite implant 4700 that includes outer member 4710 (e.g. sleeve) and inner member 4730 (e.g. shank). The inner member, like any of the inner members herein, can include a proximal end 4760 that is configured to be coupled to a tulip, to which a reinforcing rod may be secured (details of which are described herein). As set forth herein, different regions of the implant can be configured to facilitate one or more functions once implanted (e.g. distal anchoring region, growth region, proximal anchoring region, etc.). Those regions can have lengths such that when implanted based on a trajectory (or range of general trajectories, such as posterior sacral alar-iliac (“SAI”) trajectories) the regions will be adjacent certain anatomical regions to better adapt them to perform those functions than other regions of the implant.

In some embodiments, a distal anchoring region (“DAR” in FIG. 47) of an implant (e.g. composite implant) may have a length from 15 mm to 40 mm, such as from 15 mm to 35 mm, such as from 15 mm to 30 mm, such as from 20 mm to 30 mm, such as 25 mm.

In some embodiments, a growth region (e.g. “GR” in FIG. 47) of an implant (e.g. a composite implant) may have a length from 25 mm to 65 mm, such as from 30 mm to 60 mm, such as 30 mm to 55 mm, such as 35 mm to 55 mm, such as 45 mm.

In some embodiments, a proximal anchoring region (e.g. “PAR” in FIG. 47) of an implant (e.g. a composite implant) may be from 3 mm to 20 mm, such as 5 mm to 15 mm.

In some embodiments, an overall screw length of the implant (such as a composite implant), which may a combination of DAR, GR, and PAR, in some embodiments, may be from 60 mm-100 mm, such as 65 mm to 95 mm, such as 70 mm, to 90 mm, such as 75 mm to 85 mm, such as 80 mm.

In some embodiments, an overall implant length (such as a composite implant), which may a combination of DAR, GR, optional PAR, and proximal coupling region 4760, may be from 65 mm-110 mm, such as 70 mm to 105 mm, such as 75 mm, to 100 mm, such as 80 mm to 95 mm, such as 85 mm.

With reference to FIG. 47, in methods of use, distal anchoring region DAR may be implanted in an ilium. Growth region GR may be implanted across an SI joint, and proximal anchoring region PAR may be implanted in a sacrum. A tulip can be coupled to proximal coupling region 4760, and a stabilizing rod can be secured to the tulip. More than one composite implant can be positioned across an SI joint in the trajectories described herein. One or more stabilizing rods may be secured to any number of implanted composite implants herein.

One aspect of this disclosure is related to bone stabilizing implant that includes one or more deployable members, the one or more deployable members having non-deployed configurations and a deployed configuration. FIGS. 48A-48H illustrate an exemplary embodiment of a bone stabilizing implant that includes one or more deployable members. FIG. 48A is a perspective view of exemplary bone stabilizing implant 4800 including an elongate implant body 4802 and a plurality of deployable members 4804 and 4804′ (only some or each are labeled for clarity). The deployable members in this embodiment may be referred to as protrusions or fins, and in FIG. 48A are shown in their deployed configurations. If the term “fin” or “fins” is used in the text or figures, the more generalized term “deployable member(s)” is understood to apply as well. FIG. 48B shows deployable members in deployed configurations/positions, while FIG. 48C shows the deployable members in non-deployed (e.g., recessed) configurations/positions.

FIG. 48D shows a side view of implant 4800. FIG. 48D illustrates threads of the elongate implant body 4802 pass through openings between adjacent deployable members 4804. The threads thereby provide a mechanical stop for the deployable members 4804 by limiting upward travel, and prevent the opening from bowing under load. The deployable members are deployed.

FIG. 48E shows a perspective sectional view of the implant in the region shown in FIG. 48D. FIG. 48E shows internal deployment member 4810, which can be part of the implant or a deployment tool that is not part of the implant and is removed from the patient following the deployment step. The internal deployment member can be function as a camming member, and when rotated has camming surfaces that urge the deployable member(s) radially outward to their deployed positions/configurations. The internal deployment member 4810 may stay in place with the implant, and may help the deployable members stay in their deployed configurations. The openings 4820 in the elongate body 4802 (through which the deployable members extend), one of which is labeled in FIG. 48G can be tapered to limit the play between the deployable members and the elongate implant body 4802. In some embodiments the internal deployment member 4810 may be made titanium (for example without limitation), and may be manufactured with subtractive manufacturing techniques. The deployable member(s) may in some embodiments be titanium (for example without limitation), and can be manufactured using subtractive manufacturing techniques.

FIG. 48F shows an exemplary exploded view of implant 4800. Implant 4800 includes elongate body or sleeve 4802, which is threaded as shown and includes a plurality of sets of linear openings 4820 separated by the threads. The implant includes deployable or expandable members 4804, which in this embodiment are each coupled to a spine from which each of the deployable members 4804 extends, as shown in FIG. 48F. The spine and deployable members may be integrally formed from the same material or not. The linear spine and deployable members are disposed within the body 4802, and urged radially outward by actuation member 4810, details of which are shown in FIG. 48E. Threaded tip 4820 can be coupled to the distal end region of body 4802 using a variety of coupling techniques.

FIGS. 48G and 48H illustrate perspective sectional views of implant 4800 in non-deployed (FIG. 48G) and deployed (FIG. 48H) configurations. Additional details are shown in other figures within FIG. 48A-48F.

Exemplary methods of implanting implant 4800 can include one or more of following steps, and may not necessary be in the order that follows. During implant insertion, the deployable members 4804, 4804′, 4804″ are in non-deployed (e.g. recessed) positions relative to implant body 4802. The implant can be threaded into bone similar to a screw. After the implant is located in a target location, the deployable members can be deployed by actuating the inner actuation member, such as by rotating the inner actuating member, which may include one or more camming surfaces. The deployed member (e.g., 4804) are configured, once deployed, to aid in preventing joint rotation, thereby increasing the stability of the joint. The elongate body 4804, which can include any features of any sleeve herein, can include one or more growth features (e.g., fenestrations, lattice sections) to facilitate one or more of bony on-growth, in-growth, or through-growth.

Implant 4800 is an example of an implant with an elongate implant body that includes one or more threads, optionally a plurality of regions having different number of leads.

Implant 4800 is an example of an implant with an elongate body (e.g. 4802) that includes a plurality of rows of openings (optionally linear rows), each of the rows including a plurality of openings separated by a portion of the elongate implant body.

Implant 4800 is an example of an implant with an elongate implant body that separates a plurality of openings, wherein the separating portion includes one or more threads.

Implant 4800 is an example of an implant with deployable members, wherein any of the deployable members include a plurality of protrusions extending from a spine, the protrusions extending further radially outward than the spine, and optionally the protrusions formed integrally with the spine.

Implant 4800 is an example of an implant with one or more deployable members that are positioned relative to an elongate implant body 4802 such that they are deployed upon actuation of an internal deployment member.

Implant 4800 is an example of an implant wherein an internal deployment member comprises a plurality of radially protruding camming surfaces that when rotated cause one or more deployable members to move radially outward.

Implant 4800 is an example of an implant with one or more threads on an elongate implant body, wherein the threads provide a mechanical radial stop to one or more deployable members, optionally preventing the opening(s) from bowing under load.

Implant 4800 is an example of an implant with an implant body with openings that can be tapered to limit play between the elongate implant body and the one or more deployable members.

Implant 4800 is an example of an implant with an elongate implant body that can have one or more porous surfaces.

Implant 4800 is an example of an implant with a plurality of deployable members that can be actuated and deployed by an inner actuatable member.

Any of the composite implants herein can include a volume defined by an inner surface of the sleeve and an outer surface of the shank. That is, a gap can exist between the outer surface of the shank and the inner surface of the sleeve. The volume can facilitate bony ingrowth.

As set forth above, when the composite implants herein are advanced via a posterior sacral alar-iliac (“SAI”) trajectory and disposed across an SI joint, it can be advantageous when certain regions of the implant are adjacent certain bone or tissue once fully implanted. As set forth above, the distal region of the implant is generally configured to be able to better anchor into relatively denser cortical bone, such as with a dual threaded distal region. With some of the composite implants above (e.g. FIG. 34A), the sleeve is tapered in a distal region and includes a dual threaded region. A central region of the sleeve proximal to the distal tapered region (which can be part of an implant growth region) may be single thread (e.g. FIG. 34A), and can have one or more growth features configured to better facilitate at least one of bony on-growth, in-growth, or through-growth than the distal anchoring region. For example, in several examples herein (e.g. FIGS. 34-47), the central growth region includes at least one of one or more fenestrations or one or more lattice sections, examples of each are provided herein. Some sleeves herein can optionally also include a dual-lead proximal end region, such as in FIG. 31, 33C, 34A, 36A, 41A, 44A, which can better configure the composite implant proximal region to anchor into the more dense cortex of the sacrum. In some embodiments, the sleeve may have a central region with a single lead, a proximal region with a multi-lead (e.g. dual), and optionally a distal region that is multi-lead (e.g. dual lead).

In some methods of use, the implants herein (e.g. the composite implants) as delivered with a posterior sacral alar-iliac (“SAI”) trajectory. Without intending to be limiting, there can be benefits to implanting any of the composite implants herein such that at least 15 mm of the implant extends distal to the SI joint in the final implanted position. In some methods of use the implants extend at least 15 mm-20 mm beyond the SI joint. The distal anchoring region thus can have lengths that facilitate a distal anchoring region of the implant extending at least 15 mm beyond the joint. This can help ensure the implant distal anchoring region extends into the dense cortical ilium bone and helps anchor the implant.

Any of the sleeves herein include an inner lumen, the inner lumen sized and configured to receive at least a portion of an inner member (e.g. inner shank).

Variations and modifications of the devices and methods disclosed herein will be readily apparent to persons skilled in the art. As such, it should be understood that the foregoing detailed description and the accompanying illustrations, are made for purposes of clarity and understanding, and are not intended to limit the scope of the invention, which is defined by the claims appended hereto. Any feature described in any one embodiment described herein can be combined with any other feature of any of the other embodiment whether preferred or not.

It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference for all purposes.

Claims

1. A composite implant for stabilizing a sacroiliac (“SI”) joint, comprising: a monolithic inner shank including one or more threads in a distal threaded region; andan outer sleeve comprising one or more outer threads that are in the same direction as the one or more threads in the distal threaded region of the inner shank, and a plurality of surface growth features that are sized and configured to facilitate at least one of bony on-growth, in-growth, or through-growth, wherein the plurality of surface growth features include a plurality of lattice sections extending through at least an outer surface of the outer sleeve, wherein each of the plurality of lattice section includes pores having dimensions smaller than each of a plurality of outer sleeve fenestrations that extend through the outer sleeve, wherein a set of lattice sections are disposed in a partial helical configuration along the composite implant, the outer sleeve disposed about a central portion of the monolithic inner shank with at least a portion of the outer sleeve coupled to the inner shank,the composite implant further comprising a distal anchoring region that includes the distal threaded region of the monolithic inner shank, and a growth region that includes the plurality of surface growth features and that is proximal to the distal anchoring region, the distal anchoring region better adapted to anchor into iliac bone than the growth region, and the plurality of surface growth features better configured to facilitate the at least one of bony on-growth, in-growth, or through-growth than the anchoring region.
2. The composite implant of claim 1, further comprising a multi-lead threaded distal region that includes the distal threaded region of the inner shank,a single-lead threaded central region that is proximal to the multi-lead threaded distal region and that comprises one of the outer sleeve one or more outer threads, and multi-lead threaded proximal region proximal to the single-lead threaded central region.
3. The composite implant of claim 2, wherein the outer sleeve comprises the multi-lead threaded proximal region.
4. The composite implant of claim 2, wherein the monolithic inner shank comprises the multi-lead threaded proximal region.
5. The composite implant of claim 1, wherein in a region between an outer sleeve distal end and an outer sleeve proximal end, the inner shank is more resistant to fatigue than the sleeve.
6. The composite implant of claim 1, wherein the inner shank is made of one or more of titanium or stainless steel.
7. The composite implant of claim 6, wherein the outer sleeve is a 3D printed outer sleeve.
8. The composite implant of claim 1, wherein the one or more outer threads of the outer sleeve comprise a dual-lead thread region and a single-lead thread region.
9. The composite implant of claim 1, wherein at least half of the plurality of fenestrations are disposed axially in between one or more outer sleeve thread crests.
10. The composite implant of claim 1, wherein each of the plurality of fenestrations are disposed axially in between one or more outer sleeve thread crests.
11. The composite implant of claim 1, wherein a subset of the plurality of fenestrations are disposed in an at least partial helical configuration.
12. The composite implant of claim 11, wherein a second subset of the plurality of fenestrations are disposed in an at least partial helical configuration.
13. The composite implant of claim 1, wherein one or more of the plurality of fenestrations are tapered and have an outer dimension that is larger than an inner dimension.
14. The composite implant of claim 1, wherein a first group of the plurality of lattice sections extend all the way through a thickness of the outer sleeve, and a second group of the plurality of lattice sections only extend through an outer surface of the outer sleeve and not all the way through the thickness of the sleeve.
15. The composite implant of claim 1, wherein the plurality of lattice sections do not extend all the way through a thickness of the outer sleeve.
16. The composite implant of claim 15, wherein the subset of the plurality of lattice sections are disposed inside of a sleeve flute.
17. The composite implant of claim 15, wherein a second subset of the plurality of lattice sections extend all the way through the outer sleeve.
18. The composite implant of claim 15, wherein the plurality of lattice sections are disposed axially adjacent at least one sleeve thread.
19. The composite implant of claim 1, wherein the inner shank is stiffer than the outer sleeve.
20. The composite implant of claim 1, wherein the outer sleeve is not interfaced with the inner shank in the central portion.
21. A composite implant for stabilizing a sacroiliac (“SI”) joint, comprising: a monolithic inner shank including one or more threads in a distal threaded region; andan outer sleeve comprising one or more outer threads that are in the same direction as the one or more threads in the distal threaded region of the inner shank, and a plurality of surface growth features that are sized and configured to facilitate at least one of bony on-growth, in-growth, or through-growth, wherein the plurality of surface growth features include a plurality of lattice sections extending through at least an outer surface of the outer sleeve, wherein each of the plurality of lattice section includes pores having dimensions smaller than each of a plurality of outer sleeve fenestrations that extend through the outer sleeve, and wherein a set of lattice sections are disposed in a partial helical configuration along the composite implant,the outer sleeve disposed about a central portion of the monolithic inner shank with at least a portion of the outer sleeve coupled to the inner shank.
22. The composite implant of claim 21, further comprising a multi-lead threaded distal region that includes the distal threaded region of the inner shank,a single-lead threaded central region that is proximal to the multi-lead threaded distal region and that comprises one of the outer sleeve one or more outer threads, and multi-lead threaded proximal region proximal to the single-lead threaded central region.
23. The composite implant of claim 22, wherein the outer sleeve comprises the multi-lead threaded proximal region.
24. The composite implant of claim 22, wherein the monolithic inner shank comprises the multi-lead threaded proximal region.
25. The composite implant of claim 21, wherein in a region between an outer sleeve distal end and an outer sleeve proximal end, the inner shank is more resistant to fatigue than the sleeve.
26. The composite implant of claim 21, wherein the inner shank is made of one or more of titanium or stainless steel.
27. The composite implant of claim 26, wherein the outer sleeve is a 3D printed outer sleeve.
28. The composite implant of claim 21, wherein the one or more outer threads of the outer sleeve comprise a dual-lead thread region and a single-lead thread region.
29. The composite implant of claim 21, wherein at least half of the plurality of fenestrations are disposed axially in between one or more outer sleeve thread crests.
30. The composite implant of claim 21, wherein each of the plurality of fenestrations are disposed axially in between one or more outer sleeve thread crests.
31. The composite implant of claim 21, wherein a subset of the plurality of fenestrations are disposed in an at least partial helical configuration.
32. The composite implant of claim 31, wherein a second subset of the plurality of fenestrations are disposed in an at least partial helical configuration.
33. The composite implant of claim 21, wherein one or more of the plurality of fenestrations are tapered and have an outer dimension that is larger than an inner dimension.
34. The composite implant of claim 21, wherein a first group of the plurality of lattice sections extend all the way through a thickness of the outer sleeve, and a second group of the plurality of lattice sections only extend through an outer surface of the outer sleeve and not all the way through the thickness of the sleeve.
35. The composite implant of claim 21, wherein the plurality of lattice sections do not extend all the way through a thickness of the outer sleeve.
36. The composite implant of claim 35, wherein the plurality of lattice sections are disposed inside of a sleeve flute.
37. The composite implant of claim 35, wherein a second subset of the plurality of lattice sections extend all the way through the outer sleeve.
38. The composite implant of claim 35, wherein the plurality of lattice sections are disposed axially adjacent at least one sleeve thread.
39. The composite implant of claim 21, wherein the inner shank is stiffer than the outer sleeve.
40. The composite implant of claim 21, wherein the outer sleeve is not interfaced with the inner shank in the central portion.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/874,149, filed May 14, 2020, which is a continuation of International Application No. PCT/US2020/018402, filed Feb. 14, 2020, which claims priority to U.S. application Ser. No. 16/276,430, filed Feb. 14, 2019, U.S. Provisional Application No. 62/859,646, filed Jun. 10, 2019, and U.S. Provisional Application No. 62/933,250, filed Nov. 8, 2019; all of the disclosures of which are incorporated by reference herein for all purposes.

US Referenced Citations (973)

Number	Name	Date	Kind
1951278	Ericsson	Mar 1934	A
2136471	Schneider	Nov 1938	A
2243717	Moreira	May 1941	A
2414882	Longfellow	Jul 1947	A
2562419	Ferris	Jul 1951	A
2675801	Bambara et al.	Apr 1954	A
2697433	Zehnder	Dec 1954	A
3076453	Tronzo	Feb 1963	A
3506982	Steffee	Apr 1970	A
3694821	Moritz	Oct 1972	A
3709218	Halloran	Jan 1973	A
3744488	Cox	Jul 1973	A
4059115	Jumashev et al.	Nov 1977	A
4156943	Collier	Jun 1979	A
4197645	Scheicher	Apr 1980	A
4292964	Ulrich	Oct 1981	A
4341206	Perrett et al.	Jul 1982	A
4344190	Lee et al.	Aug 1982	A
4399813	Barber	Aug 1983	A
4423721	Otte et al.	Jan 1984	A
4475545	Ender	Oct 1984	A
4501269	Bagby	Feb 1985	A
4569338	Edwards	Feb 1986	A
4612918	Slocum	Sep 1986	A
4622959	Marcus	Nov 1986	A
4630601	Harder et al.	Dec 1986	A
4638799	Moore	Jan 1987	A
4657550	Daher	Apr 1987	A
4743256	Brantigan	May 1988	A
4773402	Asher et al.	Sep 1988	A
4787378	Sodhi	Nov 1988	A
4790303	Steffee	Dec 1988	A
4834757	Brantigan	May 1989	A
4846162	Moehring	Jul 1989	A
4877019	Vives	Oct 1989	A
4878915	Brantigan	Nov 1989	A
4898186	Ikada et al.	Feb 1990	A
4904261	Dove et al.	Feb 1990	A
4950270	Bowman et al.	Aug 1990	A
4961740	Ray et al.	Oct 1990	A
4969888	Scholten et al.	Nov 1990	A
4981481	Kranz et al.	Jan 1991	A
5034011	Howland	Jul 1991	A
5034013	Kyle et al.	Jul 1991	A
5035697	Frigg	Jul 1991	A
5041113	Wasilewski	Aug 1991	A
5053035	McLaren	Oct 1991	A
5059193	Kuslich	Oct 1991	A
5066296	Chapman et al.	Nov 1991	A
5098434	Serbousek	Mar 1992	A
5102414	Kirsch	Apr 1992	A
5108397	White	Apr 1992	A
5122141	Simpson et al.	Jun 1992	A
5139498	Astudillo Ley	Aug 1992	A
5139500	Schwartz	Aug 1992	A
5147367	Ellis	Sep 1992	A
5147402	Bohler et al.	Sep 1992	A
5190551	Chin et al.	Mar 1993	A
5197961	Castle	Mar 1993	A
5242444	MacMillan	Sep 1993	A
5298254	Prewett et al.	Mar 1994	A
5334205	Cain	Aug 1994	A
5380325	Lahille et al.	Jan 1995	A
5390683	Pisharodi	Feb 1995	A
5433718	Brinker	Jul 1995	A
5443466	Shah	Aug 1995	A
5458638	Kuslich et al.	Oct 1995	A
5470334	Ross et al.	Nov 1995	A
5480402	Kim	Jan 1996	A
5569249	James et al.	Oct 1996	A
5591235	Kuslich	Jan 1997	A
5593409	Michelson	Jan 1997	A
5607424	Tropiano	Mar 1997	A
5609635	Michelson	Mar 1997	A
5609636	Kohrs et al.	Mar 1997	A
5626616	Speece	May 1997	A
5643264	Sherman et al.	Jul 1997	A
5645599	Samani	Jul 1997	A
5658337	Kohrs et al.	Aug 1997	A
5667510	Combs	Sep 1997	A
5669909	Zdeblick et al.	Sep 1997	A
5672178	Petersen	Sep 1997	A
5683391	Boyd	Nov 1997	A
5709683	Bagby	Jan 1998	A
5713904	Errico et al.	Feb 1998	A
5716358	Ochoa et al.	Feb 1998	A
5725581	Brånemark	Mar 1998	A
5743912	LaHille et al.	Apr 1998	A
5759035	Ricci	Jun 1998	A
5766174	Perry	Jun 1998	A
5766252	Henry et al.	Jun 1998	A
5766261	Neal et al.	Jun 1998	A
5788699	Bobst et al.	Aug 1998	A
5800440	Stead	Sep 1998	A
5868749	Reed	Feb 1999	A
5897556	Drewry et al.	Apr 1999	A
5928239	Mirza	Jul 1999	A
5941885	Jackson	Aug 1999	A
5961522	Mehdizadeh	Oct 1999	A
5961554	Janson et al.	Oct 1999	A
6010507	Rudloff	Jan 2000	A
6015409	Jackson	Jan 2000	A
6030162	Huebner et al.	Feb 2000	A
6053916	Moore	Apr 2000	A
6056749	Kuslich	May 2000	A
6066175	Henderson et al.	May 2000	A
6086589	Kuslich et al.	Jul 2000	A
6096080	Nicholson et al.	Aug 2000	A
6120292	Buser et al.	Sep 2000	A
6120504	Brumback et al.	Sep 2000	A
6143031	Knothe et al.	Nov 2000	A
6197062	Fenlin	Mar 2001	B1
6206924	Timm	Mar 2001	B1
6210442	Wing et al.	Apr 2001	B1
6214049	Gayer et al.	Apr 2001	B1
6221074	Cole et al.	Apr 2001	B1
6224607	Michelson	May 2001	B1
6241732	Overaker et al.	Jun 2001	B1
6264657	Urbahns et al.	Jul 2001	B1
6270528	McKay	Aug 2001	B1
6287343	Kuslich et al.	Sep 2001	B1
6302885	Essiger	Oct 2001	B1
6302914	Michelson	Oct 2001	B1
6306140	Siddiqui	Oct 2001	B1
6319253	Ackeret et al.	Nov 2001	B1
6406498	Tormala et al.	Jun 2002	B1
6409768	Tepic et al.	Jun 2002	B1
6436139	Shapiro et al.	Aug 2002	B1
6451020	Zucherman et al.	Sep 2002	B1
6471707	Miller et al.	Oct 2002	B1
6485518	Cornwall et al.	Nov 2002	B1
6497707	Bowman et al.	Dec 2002	B1
6517541	Sesic	Feb 2003	B1
6520969	Lambrecht et al.	Feb 2003	B2
6524314	Dean et al.	Feb 2003	B1
6527775	Warburton	Mar 2003	B1
6556857	Estes et al.	Apr 2003	B1
6558386	Cragg	May 2003	B1
6565566	Wagner et al.	May 2003	B1
6575899	Foley et al.	Jun 2003	B1
6575991	Chesbrough et al.	Jun 2003	B1
6579293	Chandran	Jun 2003	B1
6582431	Ray	Jun 2003	B1
6582467	Teitelbaum et al.	Jun 2003	B1
6595998	Johnson et al.	Jul 2003	B2
6602293	Biermann et al.	Aug 2003	B1
6605090	Trieu et al.	Aug 2003	B1
6607530	Carl et al.	Aug 2003	B1
6620163	Michelson	Sep 2003	B1
6635059	Randall et al.	Oct 2003	B2
6666868	Fallin	Dec 2003	B2
6669529	Scaries	Dec 2003	B1
6673075	Santilli	Jan 2004	B2
6692501	Michelson	Feb 2004	B2
6712852	Chung et al.	Mar 2004	B1
6723099	Goshert	Apr 2004	B1
6723100	Biedermann et al.	Apr 2004	B2
6740118	Eisermann et al.	May 2004	B2
6743257	Castro	Jun 2004	B2
D493533	Blain	Jul 2004	S
6793656	Mathews	Sep 2004	B1
6827740	Michelson	Dec 2004	B1
6984235	Huebner	Jan 2006	B2
6989033	Schmidt	Jan 2006	B1
6991461	Gittleman	Jan 2006	B2
6993406	Cesarano et al.	Jan 2006	B1
7018416	Hanson et al.	Mar 2006	B2
7118579	Michelson	Oct 2006	B2
7147666	Grisoni	Dec 2006	B1
7175663	Stone	Feb 2007	B1
7211085	Michelson	May 2007	B2
7223269	Chappuis	May 2007	B2
7314488	Reiley	Jan 2008	B2
7335205	Aeschlimann et al.	Feb 2008	B2
7338500	Chappuis	Mar 2008	B2
7396365	Michelson	Jul 2008	B2
7452359	Michelson	Nov 2008	B1
7452369	Barry	Nov 2008	B2
7481831	Bonutti	Jan 2009	B2
7527649	Blain	May 2009	B1
7534254	Michelson	May 2009	B1
7537616	Branch et al.	May 2009	B1
7569054	Michelson	Aug 2009	B2
7569059	Cerundolo	Aug 2009	B2
7601155	Petersen	Oct 2009	B2
7608097	Kyle	Oct 2009	B2
7648509	Stark	Jan 2010	B2
7686805	Michelson	Mar 2010	B2
7699852	Frankel et al.	Apr 2010	B2
7708761	Petersen	May 2010	B2
7727235	Contiliano et al.	Jun 2010	B2
7758646	Khandkar et al.	Jul 2010	B2
7780704	Markworth et al.	Aug 2010	B2
7846162	Nelson et al.	Dec 2010	B2
7850732	Heinz	Dec 2010	B2
7857832	Culbert et al.	Dec 2010	B2
7887565	Michelson	Feb 2011	B2
7892265	Perez-Cruet et al.	Feb 2011	B2
7901439	Horton	Mar 2011	B2
7909832	Michelson	Mar 2011	B2
7922765	Reiley	Apr 2011	B2
7942879	Christie et al.	May 2011	B2
7951176	Grady et al.	May 2011	B2
8052728	Hestad	Nov 2011	B2
8062365	Schwab	Nov 2011	B2
8066705	Michelson	Nov 2011	B2
8066709	Michelson	Nov 2011	B2
8092505	Sommers	Jan 2012	B2
8142481	Warnick	Mar 2012	B2
8202305	Reiley	Jun 2012	B2
8221499	Lazzara et al.	Jul 2012	B2
8257398	Jackson	Sep 2012	B2
8268099	O'Neill et al.	Sep 2012	B2
8308779	Reiley	Nov 2012	B2
8308783	Morris et al.	Nov 2012	B2
8317862	Troger et al.	Nov 2012	B2
8348950	Assell et al.	Jan 2013	B2
8350186	Jones et al.	Jan 2013	B2
8388667	Reiley et al.	Mar 2013	B2
8394129	Morgenstern Lopez	Mar 2013	B2
8398635	Vaidya	Mar 2013	B2
8398682	Jackson et al.	Mar 2013	B2
8414648	Reiley	Apr 2013	B2
8425570	Reiley	Apr 2013	B2
8430930	Hunt	Apr 2013	B2
8444693	Reiley	May 2013	B2
8449585	Wallenstein et al.	May 2013	B2
8467851	Mire et al.	Jun 2013	B2
8470004	Reiley	Jun 2013	B2
8475505	Nebosky et al.	Jul 2013	B2
8529608	Terrill et al.	Sep 2013	B2
8597299	Farr et al.	Dec 2013	B2
8608802	Bagga et al.	Dec 2013	B2
D697209	Walthall et al.	Jan 2014	S
8641737	Matthis et al.	Feb 2014	B2
8663332	To et al.	Mar 2014	B1
8672986	Klaue et al.	Mar 2014	B2
8734462	Reiley et al.	May 2014	B2
8778026	Mauldin	Jul 2014	B2
8840623	Reiley	Sep 2014	B2
8840651	Reiley	Sep 2014	B2
8845693	Smith et al.	Sep 2014	B2
8858601	Reiley	Oct 2014	B2
8888827	Harper et al.	Nov 2014	B2
8894685	Mickiewicz et al.	Nov 2014	B2
8920477	Reiley	Dec 2014	B2
8926670	Jackson	Jan 2015	B2
8936623	Jackson	Jan 2015	B2
8945190	Culbert et al.	Feb 2015	B2
8945193	Kirschman	Feb 2015	B2
8951254	Mayer et al.	Feb 2015	B2
8951293	Glazer et al.	Feb 2015	B2
8951295	Matityahu et al.	Feb 2015	B2
8961571	Lee et al.	Feb 2015	B2
8979911	Martineau et al.	Mar 2015	B2
8986348	Reiley	Mar 2015	B2
RE45484	Foley et al.	Apr 2015	E
9039743	Reiley	May 2015	B2
9044321	Mauldin et al.	Jun 2015	B2
9060876	To et al.	Jun 2015	B1
9089371	Faulhaber	Jul 2015	B1
D738498	Frey et al.	Sep 2015	S
9131955	Swofford	Sep 2015	B2
9149286	Greenhalgh et al.	Oct 2015	B1
9198676	Pilgeram et al.	Dec 2015	B2
9220535	Röbling et al.	Dec 2015	B2
9314286	Bottlang et al.	Apr 2016	B2
9314348	Emstad	Apr 2016	B2
9358047	Mishra et al.	Jun 2016	B2
9358057	Whipple et al.	Jun 2016	B1
9375243	Vestgaarden	Jun 2016	B1
9375323	Reiley	Jun 2016	B2
9445852	Sweeney	Sep 2016	B2
9451999	Simpson et al.	Sep 2016	B2
9452065	Lawson	Sep 2016	B1
9486264	Reiley et al.	Nov 2016	B2
9492201	Reiley	Nov 2016	B2
9498264	Harshman et al.	Nov 2016	B2
9510872	Donner et al.	Dec 2016	B2
9517095	Vaidya	Dec 2016	B2
9526548	Asfora	Dec 2016	B2
9554909	Donner	Jan 2017	B2
9561063	Reiley	Feb 2017	B2
9566100	Asfora	Feb 2017	B2
9603613	Schoenefeld et al.	Mar 2017	B2
9603644	Sweeney	Mar 2017	B2
D783821	Folsom et al.	Apr 2017	S
9615856	Arnett et al.	Apr 2017	B2
9622783	Reiley et al.	Apr 2017	B2
9655656	Whipple	May 2017	B2
9662124	Assell et al.	May 2017	B2
9662128	Reiley	May 2017	B2
9662157	Schneider et al.	May 2017	B2
9662158	Reiley	May 2017	B2
9675394	Reiley	Jun 2017	B2
9743969	Reiley	Aug 2017	B2
9757154	Donner et al.	Sep 2017	B2
9763695	Mirda	Sep 2017	B2
9763802	Baynham	Sep 2017	B2
9775648	Greenberg et al.	Oct 2017	B2
9808298	Stroncek et al.	Nov 2017	B2
9808299	Goel et al.	Nov 2017	B2
9808337	Housman et al.	Nov 2017	B2
9820789	Reiley	Nov 2017	B2
9833321	Rindal et al.	Dec 2017	B2
9839448	Reckling et al.	Dec 2017	B2
9848889	Taylor et al.	Dec 2017	B2
9848892	Biedermann et al.	Dec 2017	B2
9883874	Vestgaarden	Feb 2018	B1
9888911	Siegal	Feb 2018	B2
9936983	Mesiwala et al.	Apr 2018	B2
9949776	Mobasser et al.	Apr 2018	B2
9949843	Reiley et al.	Apr 2018	B2
D816843	Lewis	May 2018	S
9956013	Reiley et al.	May 2018	B2
9993276	Russell	Jun 2018	B2
9993277	Krinke et al.	Jun 2018	B2
9999449	Bonutti	Jun 2018	B2
10004547	Reiley	Jun 2018	B2
10034676	Donner	Jul 2018	B2
10058430	Donner et al.	Aug 2018	B2
10064670	Mootien et al.	Sep 2018	B2
D831828	Horton et al.	Oct 2018	S
10166022	Early et al.	Jan 2019	B2
10166033	Reiley et al.	Jan 2019	B2
10179014	Menmuir et al.	Jan 2019	B1
10188403	Mirochinik et al.	Jan 2019	B2
10188442	Mazel	Jan 2019	B2
10194951	Jackson et al.	Feb 2019	B2
10194962	Schneider et al.	Feb 2019	B2
10201427	Mauldin et al.	Feb 2019	B2
10219841	Compton et al.	Mar 2019	B1
10219885	Mamo et al.	Mar 2019	B2
D846977	Williams et al.	Apr 2019	S
D847336	Asfora et al.	Apr 2019	S
10245044	Petersen	Apr 2019	B2
10245076	Fitzpatrick	Apr 2019	B2
10245087	Donner et al.	Apr 2019	B2
10258380	Sinha	Apr 2019	B2
10258393	Caploon et al.	Apr 2019	B2
10258394	Harshman et al.	Apr 2019	B2
10271882	Biedermann et al.	Apr 2019	B2
D847994	Asfora et al.	May 2019	S
10278737	Smith	May 2019	B2
10285745	Cummins et al.	May 2019	B2
10292778	Kostrzewski et al.	May 2019	B2
D850616	Asfora et al.	Jun 2019	S
10314631	Gonzalez Blohm et al.	Jun 2019	B2
10321937	Cormier et al.	Jun 2019	B2
10321945	Schifano et al.	Jun 2019	B2
10335202	Ziolo et al.	Jul 2019	B2
10335204	Matthis et al.	Jul 2019	B2
10335206	Nichols et al.	Jul 2019	B2
10335211	Chan et al.	Jul 2019	B2
10335212	Paolino et al.	Jul 2019	B2
10335216	Mari et al.	Jul 2019	B2
10335217	Lindner	Jul 2019	B2
10342586	Schneider	Jul 2019	B2
10349983	Purcell et al.	Jul 2019	B2
10349986	Wall et al.	Jul 2019	B2
10357287	Schlaepfer et al.	Jul 2019	B2
10363070	Jackson et al.	Jul 2019	B2
10363073	Raina et al.	Jul 2019	B2
10363140	Mauldin et al.	Jul 2019	B2
10363143	Neubardt	Jul 2019	B2
10368919	Pham et al.	Aug 2019	B2
10413332	Schumacher et al.	Sep 2019	B2
10426533	Mauldin et al.	Oct 2019	B2
10426539	Schifano et al.	Oct 2019	B2
10433880	Donner et al.	Oct 2019	B2
10456268	Mercier et al.	Oct 2019	B2
10463402	Biester et al.	Nov 2019	B2
10478227	Leff et al.	Nov 2019	B2
10485596	Koller et al.	Nov 2019	B2
10492841	Hartdegen et al.	Dec 2019	B2
10492921	McShane, III et al.	Dec 2019	B2
10517734	Donner	Dec 2019	B2
10531898	Boulot	Jan 2020	B2
10531904	Kolb	Jan 2020	B2
10537340	Mirochinik et al.	Jan 2020	B2
D875931	Asfora et al.	Feb 2020	S
10555758	Magee et al.	Feb 2020	B2
10588676	Kang et al.	Mar 2020	B2
10588677	McDonnell	Mar 2020	B2
10595917	Loftus	Mar 2020	B2
10596003	Donner et al.	Mar 2020	B2
10603054	Asfora et al.	Mar 2020	B2
10603055	Donner et al.	Mar 2020	B2
10603087	Brenzel et al.	Mar 2020	B2
10603176	Arnold et al.	Mar 2020	B2
10610275	Brianza	Apr 2020	B2
10610276	Lutz	Apr 2020	B2
10610370	Baynham	Apr 2020	B2
10610728	Fano et al.	Apr 2020	B2
10617453	Beckett et al.	Apr 2020	B2
10653454	Frey et al.	May 2020	B2
10653455	Lehman et al.	May 2020	B2
10660657	Slobitker et al.	May 2020	B2
10660679	Kang et al.	May 2020	B2
10660684	Kang et al.	May 2020	B2
10667923	Sullivan et al.	Jun 2020	B2
10682131	Fallin et al.	Jun 2020	B2
10682150	Stark	Jun 2020	B2
10682437	Roth	Jun 2020	B2
10711334	Patel et al.	Jul 2020	B2
10729475	Childs	Aug 2020	B2
10729482	Fantigrossi et al.	Aug 2020	B2
10743995	Fallin et al.	Aug 2020	B2
D895111	Frey et al.	Sep 2020	S
10758283	Frey et al.	Sep 2020	B2
10758285	Geist et al.	Sep 2020	B2
10792074	Jackson	Oct 2020	B2
10799277	Kulper et al.	Oct 2020	B2
10799367	Vrionis et al.	Oct 2020	B2
10806597	Soumac et al.	Oct 2020	B2
10842511	Patel et al.	Nov 2020	B2
10842634	Pasini et al.	Nov 2020	B2
D904615	Asfora et al.	Dec 2020	S
D905232	Schifano et al.	Dec 2020	S
10856922	Loke et al.	Dec 2020	B2
10864029	Redmond et al.	Dec 2020	B2
10898333	Cordaro	Jan 2021	B2
10905472	Mari et al.	Feb 2021	B2
10912654	Scheland	Feb 2021	B2
10932838	Mehl et al.	Mar 2021	B2
10939944	Wapner et al.	Mar 2021	B2
10940008	Patel	Mar 2021	B2
10959758	Mesiwala et al.	Mar 2021	B2
10959830	Williams et al.	Mar 2021	B2
10987142	Poelstra et al.	Apr 2021	B2
10993754	Kuntz et al.	May 2021	B2
10993757	Schifano et al.	May 2021	B2
11006985	Caploon et al.	May 2021	B2
D921898	Schifano et al.	Jun 2021	S
D922568	Schifano et al.	Jun 2021	S
11033309	Zadeh	Jun 2021	B2
11052229	Althoff et al.	Jul 2021	B2
11058443	Siccardi et al.	Jul 2021	B2
11071573	Schneider et al.	Jul 2021	B2
11116519	Sand et al.	Sep 2021	B2
11116557	Zander et al.	Sep 2021	B2
11147591	Jackson	Oct 2021	B2
11147597	Jackson	Oct 2021	B2
11147688	Reckling et al.	Oct 2021	B2
D935025	Schifano et al.	Nov 2021	S
11166821	Sazy	Nov 2021	B2
11172939	Donner et al.	Nov 2021	B2
11224467	Peterson et al.	Jan 2022	B2
11234830	Mesiwala	Feb 2022	B2
11259854	Thornes et al.	Mar 2022	B2
11266767	Roth et al.	Mar 2022	B2
11273043	Abbasi	Mar 2022	B1
11284798	Donner et al.	Mar 2022	B2
11284887	Hartdegen et al.	Mar 2022	B2
11291485	Mauldin et al.	Apr 2022	B2
11298747	Klein et al.	Apr 2022	B2
D951455	Ginn	May 2022	S
11318020	Bohl	May 2022	B2
11419653	Castro	Aug 2022	B2
11419654	Castro	Aug 2022	B2
11452548	Harshman et al.	Sep 2022	B2
20010012942	Estes et al.	Aug 2001	A1
20010046518	Sawhney	Nov 2001	A1
20010047207	Michelson	Nov 2001	A1
20010049529	Cachia et al.	Dec 2001	A1
20020019637	Frey et al.	Feb 2002	A1
20020029043	Ahrens et al.	Mar 2002	A1
20020038123	Visotsky et al.	Mar 2002	A1
20020049497	Mason	Apr 2002	A1
20020077641	Michelson	Jun 2002	A1
20020082598	Teitelbaum	Jun 2002	A1
20020120275	Schmieding et al.	Aug 2002	A1
20020120335	Angelucci et al.	Aug 2002	A1
20020128652	Ferree	Sep 2002	A1
20020143334	von Hoffmann et al.	Oct 2002	A1
20020143335	von Hoffmann et al.	Oct 2002	A1
20020151903	Takei et al.	Oct 2002	A1
20020169507	Malone	Nov 2002	A1
20020183858	Contiliano et al.	Dec 2002	A1
20020198527	Mückter	Dec 2002	A1
20030018336	Vandewalle	Jan 2003	A1
20030032961	Pelo et al.	Feb 2003	A1
20030050642	Schmieding et al.	Mar 2003	A1
20030065332	TenHuisen et al.	Apr 2003	A1
20030074000	Roth et al.	Apr 2003	A1
20030078660	Clifford et al.	Apr 2003	A1
20030083668	Rogers et al.	May 2003	A1
20030083688	Simonson	May 2003	A1
20030088251	Braun et al.	May 2003	A1
20030097131	Schon et al.	May 2003	A1
20030139815	Grooms et al.	Jul 2003	A1
20030181979	Ferree	Sep 2003	A1
20030181982	Kuslich	Sep 2003	A1
20030199983	Michelson	Oct 2003	A1
20030229358	Errico et al.	Dec 2003	A1
20030233146	Grinberg et al.	Dec 2003	A1
20030233147	Nicholson et al.	Dec 2003	A1
20040010315	Song	Jan 2004	A1
20040024458	Senegas et al.	Feb 2004	A1
20040034422	Errico et al.	Feb 2004	A1
20040073216	Lieberman	Apr 2004	A1
20040073314	White et al.	Apr 2004	A1
20040082955	Zirkle	Apr 2004	A1
20040087948	Suddaby	May 2004	A1
20040097927	Yeung et al.	May 2004	A1
20040106925	Culbert	Jun 2004	A1
20040117022	Marnay et al.	Jun 2004	A1
20040127990	Bartish, Jr. et al.	Jul 2004	A1
20040138750	Mitchell	Jul 2004	A1
20040138753	Ferree	Jul 2004	A1
20040147929	Biedermann et al.	Jul 2004	A1
20040158324	Lange	Aug 2004	A1
20040176287	Harrison et al.	Sep 2004	A1
20040176853	Sennett et al.	Sep 2004	A1
20040181282	Zucherman et al.	Sep 2004	A1
20040186572	Lange et al.	Sep 2004	A1
20040210221	Kozak et al.	Oct 2004	A1
20040225360	Malone	Nov 2004	A1
20040230305	Gorensek et al.	Nov 2004	A1
20040260286	Ferree	Dec 2004	A1
20040267369	Lyons et al.	Dec 2004	A1
20050015059	Sweeney	Jan 2005	A1
20050015146	Louis et al.	Jan 2005	A1
20050033435	Belliard et al.	Feb 2005	A1
20050049590	Alleyne et al.	Mar 2005	A1
20050055023	Sohngen et al.	Mar 2005	A1
20050075641	Singhatat et al.	Apr 2005	A1
20050080415	Keyer et al.	Apr 2005	A1
20050107878	Conchy	May 2005	A1
20050112397	Rolfe et al.	May 2005	A1
20050113919	Cragg et al.	May 2005	A1
20050124993	Chappuis	Jun 2005	A1
20050131409	Chervitz et al.	Jun 2005	A1
20050137605	Assell et al.	Jun 2005	A1
20050143837	Ferree	Jun 2005	A1
20050149192	Zucherman et al.	Jul 2005	A1
20050159749	Levy et al.	Jul 2005	A1
20050159812	Dinger et al.	Jul 2005	A1
20050165398	Reiley	Jul 2005	A1
20050192572	Abdelgany et al.	Sep 2005	A1
20050216082	Wilson et al.	Sep 2005	A1
20050228384	Zucherman et al.	Oct 2005	A1
20050246021	Ringeisen et al.	Nov 2005	A1
20050251146	Martz et al.	Nov 2005	A1
20050273101	Schumacher	Dec 2005	A1
20050277940	Neff	Dec 2005	A1
20060036247	Michelson	Feb 2006	A1
20060036251	Reiley	Feb 2006	A1
20060036252	Baynham et al.	Feb 2006	A1
20060054171	Dall	Mar 2006	A1
20060058793	Michelson	Mar 2006	A1
20060058800	Ainsworth et al.	Mar 2006	A1
20060062825	Maccecchini	Mar 2006	A1
20060084986	Grinberg et al.	Apr 2006	A1
20060089656	Allard et al.	Apr 2006	A1
20060111779	Petersen	May 2006	A1
20060129247	Brown et al.	Jun 2006	A1
20060142772	Ralph et al.	Jun 2006	A1
20060161163	Shino	Jul 2006	A1
20060178673	Curran	Aug 2006	A1
20060195094	McGraw et al.	Aug 2006	A1
20060217717	Whipple	Sep 2006	A1
20060241776	Brown et al.	Oct 2006	A1
20060271054	Sucec et al.	Nov 2006	A1
20060293662	Boyer, II et al.	Dec 2006	A1
20070027544	McCord et al.	Feb 2007	A1
20070038219	Matthis et al.	Feb 2007	A1
20070049933	Ahn et al.	Mar 2007	A1
20070066977	Assell et al.	Mar 2007	A1
20070083265	Malone	Apr 2007	A1
20070088362	Bonutti et al.	Apr 2007	A1
20070093841	Hoogland	Apr 2007	A1
20070093898	Schwab et al.	Apr 2007	A1
20070106383	Abdou	May 2007	A1
20070149976	Hale et al.	Jun 2007	A1
20070156144	Ulrich et al.	Jul 2007	A1
20070156241	Reiley et al.	Jul 2007	A1
20070156246	Meswania et al.	Jul 2007	A1
20070161985	Demakas et al.	Jul 2007	A1
20070161989	Heinz et al.	Jul 2007	A1
20070173820	Trieu	Jul 2007	A1
20070219634	Greenhalgh et al.	Sep 2007	A1
20070233080	Na et al.	Oct 2007	A1
20070233146	Henniges et al.	Oct 2007	A1
20070233247	Schwab	Oct 2007	A1
20070250166	McKay	Oct 2007	A1
20070270879	Isaza et al.	Nov 2007	A1
20070282443	Globerman et al.	Dec 2007	A1
20080021454	Chao et al.	Jan 2008	A1
20080021455	Chao et al.	Jan 2008	A1
20080021456	Gupta et al.	Jan 2008	A1
20080021461	Barker et al.	Jan 2008	A1
20080021480	Chin et al.	Jan 2008	A1
20080065093	Assell et al.	Mar 2008	A1
20080065215	Reiley	Mar 2008	A1
20080071356	Greenhalgh et al.	Mar 2008	A1
20080109083	Van Hoeck et al.	May 2008	A1
20080125868	Branemark et al.	May 2008	A1
20080132901	Recoules-Arche et al.	Jun 2008	A1
20080140082	Erdem et al.	Jun 2008	A1
20080147079	Chin et al.	Jun 2008	A1
20080154374	Labrom	Jun 2008	A1
20080161810	Melkent	Jul 2008	A1
20080183204	Greenhalgh et al.	Jul 2008	A1
20080234758	Fisher et al.	Sep 2008	A1
20080255562	Gil et al.	Oct 2008	A1
20080255618	Fisher et al.	Oct 2008	A1
20080255622	Mickiewicz et al.	Oct 2008	A1
20080255664	Hogendijk et al.	Oct 2008	A1
20080255666	Fisher et al.	Oct 2008	A1
20080255667	Horton	Oct 2008	A1
20080275454	Geibel	Nov 2008	A1
20080294202	Peterson et al.	Nov 2008	A1
20080306554	McKinley	Dec 2008	A1
20090012529	Blain et al.	Jan 2009	A1
20090018669	Roush	Jan 2009	A1
20090024174	Stark	Jan 2009	A1
20090036927	Vestgaarden	Feb 2009	A1
20090037148	Lin et al.	Feb 2009	A1
20090043393	Duggal et al.	Feb 2009	A1
20090082810	Bhatnagar et al.	Mar 2009	A1
20090082869	Slemker et al.	Mar 2009	A1
20090099602	Aflatoon	Apr 2009	A1
20090099610	Johnson et al.	Apr 2009	A1
20090105770	Berrevooets et al.	Apr 2009	A1
20090118771	Gonzalez-Hernandez	May 2009	A1
20090131986	Lee et al.	May 2009	A1
20090138053	Assell et al.	May 2009	A1
20090157119	Hale	Jun 2009	A1
20090163920	Hochschuler et al.	Jun 2009	A1
20090187247	Metcalf, Jr. et al.	Jul 2009	A1
20090216238	Stark	Aug 2009	A1
20090270929	Suddaby	Oct 2009	A1
20090287254	Nayet et al.	Nov 2009	A1
20090312798	Varela	Dec 2009	A1
20090319043	McDevitt et al.	Dec 2009	A1
20090324678	Thorne et al.	Dec 2009	A1
20100003638	Collins et al.	Jan 2010	A1
20100022535	Lee et al.	Jan 2010	A1
20100076502	Guyer et al.	Mar 2010	A1
20100081107	Bagambisa et al.	Apr 2010	A1
20100094290	Vaidya	Apr 2010	A1
20100094295	Schnieders et al.	Apr 2010	A1
20100094420	Grohowski	Apr 2010	A1
20100106194	Bonutti et al.	Apr 2010	A1
20100106195	Serhan et al.	Apr 2010	A1
20100114174	Jones et al.	May 2010	A1
20100114317	Lambrecht et al.	May 2010	A1
20100131011	Stark	May 2010	A1
20100137990	Apatsidis et al.	Jun 2010	A1
20100145461	Landry et al.	Jun 2010	A1
20100160977	Gephart et al.	Jun 2010	A1
20100168798	Clineff et al.	Jul 2010	A1
20100191292	DeMeo et al.	Jul 2010	A1
20100262242	Chavatte et al.	Oct 2010	A1
20100268228	Petersen	Oct 2010	A1
20100280619	Yuan et al.	Nov 2010	A1
20100280622	McKinley	Nov 2010	A1
20100286778	Eisermann et al.	Nov 2010	A1
20100331851	Huene	Dec 2010	A1
20100331893	Geist et al.	Dec 2010	A1
20110009869	Marino et al.	Jan 2011	A1
20110022089	Assell et al.	Jan 2011	A1
20110029019	Ainsworth et al.	Feb 2011	A1
20110040362	Godara et al.	Feb 2011	A1
20110046737	Teisen	Feb 2011	A1
20110060373	Russell et al.	Mar 2011	A1
20110060375	Bonutti	Mar 2011	A1
20110066190	Schaller et al.	Mar 2011	A1
20110082551	Kraus	Apr 2011	A1
20110093020	Wu	Apr 2011	A1
20110098747	Donner et al.	Apr 2011	A1
20110098816	Jacob et al.	Apr 2011	A1
20110098817	Eckhardt et al.	Apr 2011	A1
20110106175	Rezach	May 2011	A1
20110153018	Walters et al.	Jun 2011	A1
20110160866	Laurence et al.	Jun 2011	A1
20110178561	Roh	Jul 2011	A1
20110184417	Kitch et al.	Jul 2011	A1
20110184518	Trieu	Jul 2011	A1
20110184519	Trieu	Jul 2011	A1
20110184520	Trieu	Jul 2011	A1
20110196372	Murase	Aug 2011	A1
20110213432	Geist et al.	Sep 2011	A1
20110230966	Trieu	Sep 2011	A1
20110238074	Ek	Sep 2011	A1
20110238124	Richelsoph	Sep 2011	A1
20110238181	Trieu	Sep 2011	A1
20110245930	Alley et al.	Oct 2011	A1
20110257755	Bellemere et al.	Oct 2011	A1
20110264229	Donner	Oct 2011	A1
20110276098	Biedermann et al.	Nov 2011	A1
20110295272	Assell et al.	Dec 2011	A1
20110295370	Suh et al.	Dec 2011	A1
20110313471	McLean et al.	Dec 2011	A1
20110313532	Hunt	Dec 2011	A1
20110319995	Voellmicke et al.	Dec 2011	A1
20120004730	Castro	Jan 2012	A1
20120083887	Purcell et al.	Apr 2012	A1
20120095560	Donner	Apr 2012	A1
20120179256	Reiley	Jul 2012	A1
20120191191	Trieu	Jul 2012	A1
20120215315	Hochschuler et al.	Aug 2012	A1
20120226318	Wenger et al.	Sep 2012	A1
20120253398	Metcalf et al.	Oct 2012	A1
20120259372	Glazer	Oct 2012	A1
20120271424	Crawford	Oct 2012	A1
20120277866	Kalluri et al.	Nov 2012	A1
20120296428	Donner	Nov 2012	A1
20120323285	Assell et al.	Dec 2012	A1
20130018427	Pham et al.	Jan 2013	A1
20130030456	Assell et al.	Jan 2013	A1
20130030529	Hunt	Jan 2013	A1
20130035727	Datta	Feb 2013	A1
20130053852	Greenhalgh et al.	Feb 2013	A1
20130053854	Schoenefeld et al.	Feb 2013	A1
20130053902	Trudeau	Feb 2013	A1
20130053963	Davenport	Feb 2013	A1
20130072984	Robinson	Mar 2013	A1
20130085535	Greenhalgh et al.	Apr 2013	A1
20130096683	Kube	Apr 2013	A1
20130116793	Kloss	May 2013	A1
20130123850	Schoenefeld et al.	May 2013	A1
20130123935	Hunt et al.	May 2013	A1
20130131678	Dahners	May 2013	A1
20130144343	Arnett et al.	Jun 2013	A1
20130158609	Mikhail et al.	Jun 2013	A1
20130172736	Abdou	Jul 2013	A1
20130197590	Assell et al.	Aug 2013	A1
20130203088	Baerlecken et al.	Aug 2013	A1
20130218215	Ginn et al.	Aug 2013	A1
20130218282	Hunt	Aug 2013	A1
20130231746	Ginn et al.	Sep 2013	A1
20130237988	Mauldin	Sep 2013	A1
20130245703	Warren et al.	Sep 2013	A1
20130245763	Mauldin	Sep 2013	A1
20130267836	Mauldin et al.	Oct 2013	A1
20130267961	Mauldin et al.	Oct 2013	A1
20130267989	Mauldin et al.	Oct 2013	A1
20130274890	McKay	Oct 2013	A1
20130325129	Huang	Dec 2013	A1
20140012334	Armstrong et al.	Jan 2014	A1
20140012340	Beck et al.	Jan 2014	A1
20140031934	Trieu	Jan 2014	A1
20140031935	Donner et al.	Jan 2014	A1
20140031938	Lechmann et al.	Jan 2014	A1
20140031939	Wolfe et al.	Jan 2014	A1
20140046380	Asfora	Feb 2014	A1
20140074175	Ehler et al.	Mar 2014	A1
20140088596	Assell et al.	Mar 2014	A1
20140088707	Donner et al.	Mar 2014	A1
20140121776	Hunt	May 2014	A1
20140135927	Pavlov et al.	May 2014	A1
20140142700	Donner et al.	May 2014	A1
20140172027	Biedermann et al.	Jun 2014	A1
20140200618	Donner et al.	Jul 2014	A1
20140207240	Stoffman et al.	Jul 2014	A1
20140257294	Gedet et al.	Sep 2014	A1
20140257408	Trieu et al.	Sep 2014	A1
20140276846	Mauldin et al.	Sep 2014	A1
20140276851	Schneider et al.	Sep 2014	A1
20140277139	Vrionis et al.	Sep 2014	A1
20140277165	Katzman et al.	Sep 2014	A1
20140277460	Schifano et al.	Sep 2014	A1
20140277462	Yerby et al.	Sep 2014	A1
20140277463	Yerby et al.	Sep 2014	A1
20140288649	Hunt	Sep 2014	A1
20140288650	Hunt	Sep 2014	A1
20140296982	Cheng	Oct 2014	A1
20140330382	Mauldin	Nov 2014	A1
20140364917	Sandstrom et al.	Dec 2014	A1
20150012051	Warren et al.	Jan 2015	A1
20150039037	Donner et al.	Feb 2015	A1
20150080951	Yeh	Mar 2015	A1
20150080972	Chin et al.	Mar 2015	A1
20150094765	Donner et al.	Apr 2015	A1
20150112444	Aksu	Apr 2015	A1
20150147397	Altschuler	May 2015	A1
20150150683	Donner et al.	Jun 2015	A1
20150173805	Donner et al.	Jun 2015	A1
20150173904	Stark	Jun 2015	A1
20150182268	Donner et al.	Jul 2015	A1
20150190149	Assell et al.	Jul 2015	A1
20150190187	Parent et al.	Jul 2015	A1
20150209094	Anderson	Jul 2015	A1
20150216566	Mikhail et al.	Aug 2015	A1
20150238203	Asfora	Aug 2015	A1
20150250513	De Lavigne Sainte	Sep 2015	A1
20150250611	Schifano et al.	Sep 2015	A1
20150250612	Schifano et al.	Sep 2015	A1
20150257892	Lechmann et al.	Sep 2015	A1
20150313720	Lorio	Nov 2015	A1
20150320450	Mootien et al.	Nov 2015	A1
20150320451	Mootien et al.	Nov 2015	A1
20150320469	Biedermann et al.	Nov 2015	A1
20150342753	Donner et al.	Dec 2015	A1
20160000488	Cross, III	Jan 2016	A1
20160022429	Greenhalgh et al.	Jan 2016	A1
20160095711	Castro	Apr 2016	A1
20160095721	Schell et al.	Apr 2016	A1
20160100870	Lavigne et al.	Apr 2016	A1
20160106477	Hynes et al.	Apr 2016	A1
20160106479	Hynes et al.	Apr 2016	A1
20160120661	Schell et al.	May 2016	A1
20160143671	Jimenez	May 2016	A1
20160157908	Cawley et al.	Jun 2016	A1
20160166301	Papangelou et al.	Jun 2016	A1
20160175113	Lins	Jun 2016	A1
20160184103	Fonte et al.	Jun 2016	A1
20160213487	Wilson et al.	Jul 2016	A1
20160242820	Whipple et al.	Aug 2016	A1
20160242912	Lindsey et al.	Aug 2016	A1
20160249940	Stark	Sep 2016	A1
20160287171	Sand et al.	Oct 2016	A1
20160287301	Mehl et al.	Oct 2016	A1
20160310188	Marino et al.	Oct 2016	A1
20160310197	Black et al.	Oct 2016	A1
20160324643	Donner et al.	Nov 2016	A1
20160324656	Morris et al.	Nov 2016	A1
20160374727	Greenhalgh et al.	Dec 2016	A1
20170014235	Jones et al.	Jan 2017	A1
20170020573	Cain et al.	Jan 2017	A1
20170020585	Harshman et al.	Jan 2017	A1
20170049488	Vestgaarden	Feb 2017	A1
20170086885	Duncan et al.	Mar 2017	A1
20170128083	Germain	May 2017	A1
20170128214	Mayer	May 2017	A1
20170135733	Donner et al.	May 2017	A1
20170135737	Krause	May 2017	A1
20170143513	Sandstrom et al.	May 2017	A1
20170156879	Janowski	Jun 2017	A1
20170156880	Halverson et al.	Jun 2017	A1
20170202511	Chang et al.	Jul 2017	A1
20170209155	Petersen	Jul 2017	A1
20170216036	Cordaro	Aug 2017	A1
20170224393	Lavigne et al.	Aug 2017	A1
20170246000	Pavlov et al.	Aug 2017	A1
20170258498	Redmond et al.	Sep 2017	A1
20170258506	Redmond et al.	Sep 2017	A1
20170258606	Afzal	Sep 2017	A1
20170266007	Gelaude et al.	Sep 2017	A1
20170296344	Souza et al.	Oct 2017	A1
20170303938	Rindal et al.	Oct 2017	A1
20170333205	Joly et al.	Nov 2017	A1
20170348034	LaPierre et al.	Dec 2017	A1
20170360570	Berndt et al.	Dec 2017	A1
20180008256	Fallin et al.	Jan 2018	A1
20180036041	Pham et al.	Feb 2018	A1
20180042652	Mari et al.	Feb 2018	A1
20180042735	Schell et al.	Feb 2018	A1
20180104663	Asaad	Apr 2018	A1
20180104668	Sack	Apr 2018	A1
20180110624	Arnone	Apr 2018	A1
20180116626	McShane, III et al.	Apr 2018	A1
20180200063	Kahmer et al.	Jul 2018	A1
20180214192	Roby et al.	Aug 2018	A1
20180228613	Jones et al.	Aug 2018	A1
20180228617	Srour et al.	Aug 2018	A1
20180228621	Reiley et al.	Aug 2018	A1
20180235643	Lins et al.	Aug 2018	A1
20180243097	Jones et al.	Aug 2018	A1
20180256232	Russell	Sep 2018	A1
20180256351	Bishop et al.	Sep 2018	A1
20180256352	Nyahay et al.	Sep 2018	A1
20180256361	Bishop et al.	Sep 2018	A1
20180280139	Jones et al.	Oct 2018	A1
20180280140	Jones et al.	Oct 2018	A1
20180289504	Arthurs et al.	Oct 2018	A1
20180296227	Meek et al.	Oct 2018	A1
20180296347	Hamzey et al.	Oct 2018	A1
20180296363	Berry	Oct 2018	A1
20180303520	Rajpal	Oct 2018	A1
20180303623	Shoshtaev	Oct 2018	A1
20180303624	Shoshtaev	Oct 2018	A1
20180317971	Prevost	Nov 2018	A1
20180360512	Mari	Dec 2018	A1
20180368894	Wieland et al.	Dec 2018	A1
20190000636	Kim et al.	Jan 2019	A1
20190008562	Melton et al.	Jan 2019	A1
20190046684	Roth	Feb 2019	A1
20190076258	Black et al.	Mar 2019	A1
20190076266	Trudeau et al.	Mar 2019	A1
20190083270	Milz et al.	Mar 2019	A1
20190091027	Asaad et al.	Mar 2019	A1
20190117827	Roth	Apr 2019	A1
20190125371	Asfora et al.	May 2019	A1
20190125408	Asfora et al.	May 2019	A1
20190133613	Reiley et al.	May 2019	A1
20190133769	Tetsworth et al.	May 2019	A1
20190133783	Unger et al.	May 2019	A1
20190142606	Freudenberger	May 2019	A1
20190150910	Jones et al.	May 2019	A1
20190151113	Sack	May 2019	A1
20190151114	Sack	May 2019	A1
20190159901	Mauldin et al.	May 2019	A1
20190183653	Gregersen et al.	Jun 2019	A1
20190231554	Bishop et al.	Aug 2019	A1
20190239935	Willis et al.	Aug 2019	A1
20190247094	Yacoub	Aug 2019	A1
20190254840	Gray et al.	Aug 2019	A1
20190262048	Sutika	Aug 2019	A1
20190262049	Tempco et al.	Aug 2019	A1
20190290441	Tong et al.	Sep 2019	A1
20190298528	Lindsey et al.	Oct 2019	A1
20190298542	Kloss	Oct 2019	A1
20190328546	Palagi et al.	Oct 2019	A1
20190343564	Tempco et al.	Nov 2019	A1
20190343565	Tempco et al.	Nov 2019	A1
20190343566	Tempco et al.	Nov 2019	A1
20190343567	Tempco et al.	Nov 2019	A1
20190343640	Donner et al.	Nov 2019	A1
20190343641	Mauldin et al.	Nov 2019	A1
20190343644	Ryan et al.	Nov 2019	A1
20190343645	Miccio et al.	Nov 2019	A1
20190343652	Petersheim et al.	Nov 2019	A1
20190343653	McKay	Nov 2019	A1
20190388131	Mehl et al.	Dec 2019	A1
20190388228	Donner et al.	Dec 2019	A1
20190388242	Harris et al.	Dec 2019	A1
20200000595	Jones et al.	Jan 2020	A1
20200008817	Reiley et al.	Jan 2020	A1
20200022817	Cressgrove et al.	Jan 2020	A1
20200038069	Jones et al.	Feb 2020	A1
20200046512	Newman et al.	Feb 2020	A1
20200069431	Boehm et al.	Mar 2020	A1
20200093603	Manwill et al.	Mar 2020	A1
20200100822	Lipow	Apr 2020	A1
20200129214	Pepper et al.	Apr 2020	A1
20200138485	Kuwamura et al.	May 2020	A1
20200138492	Kavanagh	May 2020	A1
20200146721	Sadiq	May 2020	A1
20200149137	Roth	May 2020	A1
20200170679	Sciubba et al.	Jun 2020	A1
20200206390	Roth	Jul 2020	A1
20200222088	Kraus	Jul 2020	A1
20200222195	Assell et al.	Jul 2020	A1
20200246158	Bergey	Aug 2020	A1
20200254140	Roth	Aug 2020	A1
20200261240	Mesiwala et al.	Aug 2020	A1
20200268518	Suh et al.	Aug 2020	A1
20200315647	Fojtik et al.	Oct 2020	A1
20200315666	Nichols et al.	Oct 2020	A1
20200315669	Dejardin	Oct 2020	A1
20200323563	Rezach et al.	Oct 2020	A1
20200345507	Reiley	Nov 2020	A1
20200345508	Reiley	Nov 2020	A1
20200345509	Reiley	Nov 2020	A1
20200345510	Reiley	Nov 2020	A1
20200375750	Abbasi et al.	Dec 2020	A1
20200397491	Frey et al.	Dec 2020	A1
20210022882	Dang et al.	Jan 2021	A1
20210107093	Tempco	Apr 2021	A1
20210153911	Stuart et al.	May 2021	A1
20210169660	Reckling et al.	Jun 2021	A1
20210212734	Mesiwala et al.	Jul 2021	A1
20210212833	Chin et al.	Jul 2021	A1
20210228360	Hunt et al.	Jul 2021	A1
20210236146	Donner et al.	Aug 2021	A1
20210338454	Afzal	Nov 2021	A1
20210346038	Fiechter et al.	Nov 2021	A1
20210353337	Kaufmann et al.	Nov 2021	A1
20210353338	Meek et al.	Nov 2021	A1
20210393408	Ginn	Dec 2021	A1
20210393409	Ginn	Dec 2021	A1
20220031474	Reckling et al.	Feb 2022	A1
20220096098	Sand et al.	Mar 2022	A1
20220249146	Mauldin et al.	Aug 2022	A1
20220273447	Ginn	Sep 2022	A1
20220273448	Ginn et al.	Sep 2022	A1
20220296377	Ginn et al.	Sep 2022	A1
20220296378	Ginn	Sep 2022	A1
20220304813	Ginn et al.	Sep 2022	A1
20220304814	Ginn	Sep 2022	A1

Foreign Referenced Citations (68)

Number	Date	Country
1128944	Aug 1996	CN
1190882	Aug 1998	CN
1909848	Feb 2007	CN
101795632	Aug 2010	CN
102361601	Feb 2012	CN
102011001264	Sep 2012	DE
102012106336	Jan 2014	DE
1287796	Mar 2003	EP
2070481	Feb 2012	EP
2796104	Oct 2014	EP
2590576	Oct 2015	EP
2749238	Mar 2017	EP
2887899	Aug 2017	EP
2341852	Aug 2018	EP
2496162	Oct 2018	EP
3484387	May 2019	EP
3593745	Jan 2020	EP
3616634	Mar 2020	EP
3661441	Jun 2020	EP
2408389	Apr 2021	EP
59200642	Nov 1984	JP
05-176942	Jul 1993	JP
05184615	Jul 1993	JP
09149906	Oct 1997	JP
10-85231	Apr 1998	JP
11318931	Nov 1999	JP
2002509753	Apr 2002	JP
2003511198	Mar 2003	JP
2003533329	Nov 2003	JP
2003534046	Nov 2003	JP
2004121841	Apr 2004	JP
2004512895	Apr 2004	JP
2004516866	Jun 2004	JP
2006506181	Feb 2006	JP
2007535973	Dec 2007	JP
2008540036	Nov 2008	JP
2009521990	Jun 2009	JP
2009533159	Sep 2009	JP
2010137016	Jun 2010	JP
2015510506	Apr 2015	JP
WO9731517	Aug 1997	WO
WO0117445	Mar 2001	WO
WO0238054	May 2002	WO
WO03007839	Jan 2003	WO
WO0402344	Jan 2004	WO
WO2004043277	May 2004	WO
WO2005009729	Feb 2005	WO
WO2006003316	Jan 2006	WO
WO2006023793	Mar 2006	WO
WO2006074321	Jul 2006	WO
WO2006116850	Nov 2006	WO
WO2009025884	Feb 2009	WO
WO2009029074	Mar 2009	WO
WO2010105196	Sep 2010	WO
WO2011010463	Jan 2011	WO
WO2011110865	Sep 2011	WO
WO2011124874	Oct 2011	WO
WO2011149557	Dec 2011	WO
WO2012015976	Feb 2012	WO
WO2012048008	Apr 2012	WO
WO2013000071	Jan 2013	WO
WO2013052807	Apr 2013	WO
WO2013119907	Aug 2013	WO
WO2014145902	Sep 2014	WO
WO2017147140	Aug 2017	WO
WO2017147537	Aug 2017	WO
WO2020168269	Aug 2020	WO
WO2021102429	May 2021	WO

Non-Patent Literature Citations (15)

Entry
Follini et al.; U.S. Appl. No. 17/777,679 entitled “Rod coupling assemblies for bone stabilization constructs,” filed May 18, 2022.
Stuart et al.; U.S. Appl. No. 17/664,353 entitled “Bone stabilizing implants and methods of placement across SI joints,” filed May 20, 2022.
Mauldin et al.; U.S. Appl. No. 17/664,582 entitled “Integrated implant,” filed May 23, 2022.
Stuart et al.; U.S. Appl. No. 17/812,945 entitled “Sacro-iliac joint stabilizing implants and methods of implantation,” filed Jul. 15, 2022.
Mauldin et al.; U.S. Appl. No. 17/805,165 entitled “Systems, device, and methods for joint fusion,” filed Jun. 2, 2022.
Acumed; Acutrak Headless Compressioin Screw (product information); 12 pgs; © 2005; retrieved Sep. 25, 2014 from http://www.rcsed.ac.uk/fellows/Ivanrensburg/classification/surgtech/acumed/manuals/acutrak-brochure%200311.pdf.
Al-Khayer et al.; Percutaneous sacroiliac joint arthrodesis, a novel technique; J Spinal Disord Tech; vol. 21; No. 5; pp. 359-363; Jul. 2008.
Khurana et al.; Percutaneous fusion of the sacroiliac joint with hollow modular anchorage screws, clinical and radiological outcome, J Bone Joint Surg; vol. 91-B; No. 5; pp. 627-631; May 2009.
Lu et al.; Mechanical properties of porous materials; Journal of Porous Materials; 6(4); pp. 359-368; Nov. 1, 1999.
Peretz et al.; The internal bony architecture of the sacrum; Spine; 23(9); pp. 971-974; May 1, 1998.
Richards et al.; Bone density and cortical thickness in normal, osteopenic, and osteoporotic sacra; Journal of Osteoporosis; 2010(ID 504078); 5 pgs; Jun. 9, 2010.
Wise et al.; Minimally invasive sacroiliac arthrodesis, outcomes of a new technique; J Spinal Disord Tech; vol. 21; No. 8; pp. 579-584; Dec. 2008.
Schneider et al.; U.S. Appl. No. 17/443,388 entitled “Matrix implant,” filed Jul. 26, 2021.
Mesiwala et al.; U.S. Appl. No. 17/649,296 entitled “Implants for spinal fixation and or fusion,” filed Jan. 28, 2022.
Mauldin et al.; U.S. Appl. No. 17/649,544 entitled “Fenestrated implant,” filed Jan. 31, 2022.

Related Publications (1)

	Number	Date	Country
	20220287848 A1	Sep 2022	US

Provisional Applications (2)

	Number	Date	Country
	62859646	Jun 2019	US
	62933250	Nov 2019	US

Continuations (3)

	Number	Date	Country
Parent	16874149	May 2020	US
Child	17649265		US
Parent	PCT/US2020/018402	Feb 2020	US
Child	16874149		US
Parent	16276430	Feb 2019	US
Child	PCT/US2020/018402		US

Implants for spinal fixation and or fusion

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Disclaimer

Abstract